piperaquine has been researched along with Malaria, Falciparum in 322 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (0.62) | 18.2507 |
| 2000's | 43 (13.35) | 29.6817 |
| 2010's | 198 (61.49) | 24.3611 |
| 2020's | 79 (24.53) | 2.80 |
| Authors | Studies |
|---|---|
| Batty, KT; Davis, TM; Ilett, KF; Karunajeewa, HA; Lammey, J; Law, I; Lin, E; Mueller, I; Page-Sharp, M; Siba, P | 1 |
| Ashley, EA; Ashton, M; Day, NP; Lindegardh, N; McGready, R; Nosten, F; Phaiphun, L; Stepniewska, K; Tarning, J; White, NJ | 1 |
| Bui, D; Chavchich, M; Dinh, DN; Edstein, MD; Le, TT; Nguyen, DV; Nguyen, ND; Nguyen, QP; Nguyen, TD; Nguyen, TX | 1 |
| Abdirahman, A; Borrmann, S; Bull, P; Diriye, A; Kiara, SM; Marsh, K; Mwai, L; Nzila, A; Pole, L; Rippert, A | 1 |
| Greenhouse, B; Joloba, M; Kiggundu, M; Nanyunja, S; Nsobya, SL; Rosenthal, PJ | 1 |
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Chowell-Puente, G; Halsey, ES; Jones, S; Kahunu, GM; Kaputu, AK; Likwela, JL; Lucchi, N; Mavoko, HM; Moriarty, LF; Mulopo, PM; Muyembe Tamfum, JJ; Ngoyi, DM; Niang, M; Nkoli, PM; Ntamabyaliro, NY; Plucinski, MM; Rika, JM; Sadou, A; Schmedes, SE; Sompwe, EM; Subramaniam, G; Svigel, SS | 1 |
| Banda, S; Blomberg, B; Idro, R; Kühl, MJ; Mukaka, M; Nkosi-Gondwe, T; O Ter Kuile, F; Opoka, RO; Phiri, KS; Robberstad, B | 1 |
| Assefa, DG; Makonnen, E; Yismaw, G | 2 |
| Ali, AM; Aweeka, F; Dorsey, G; Duvalsaint, M; Huang, L; Hughes, E; Jagannathan, P; Kakuru, A; Kamya, MR; Legac, J; Muhindo, MK; Opira, B; Rosenthal, PJ; Savic, RM; Wallender, E; Whalen, M | 1 |
| Aweeka, F; Clark, TD; Dorsey, G; Hughes, E; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Ochieng, T; Rosenthal, PJ; Savic, RM; Wallender, E | 1 |
| Bousema, T; Brown, JM; Chen, I; Chotsiri, P; Diawara, H; Dicko, A; Gosling, R; Hoglund, RM; Koita, F; Mahamar, A; Sanogo, K; Simpson, JA; Tarning, J; White, NJ | 1 |
| Asua, V; Belay, K; Bosco, A; Bwanika, JB; Ebong, C; Gonahasa, S; Gudoi, S; Halsey, ES; Kamya, MR; Kapisi, J; Kigozi, R; Kyabayinze, D; Lucchi, NW; Moriarty, LF; Mpimbaza, A; Namuganga, JF; Niang, M; Nsobya, SL; Opigo, J; Rubahika, D; Rutazana, D; Sebikaari, G; Souza, SSS; Sserwanga, A; Tibenderana, J; Yeka, A | 1 |
| Assefa, DG; Bate, AF; Bekele, E; Makonnen, E; Mebratu, A; Mengistu, N; Molla, W; Sefa, A; Yesmaw, G; Zeleke, ED | 1 |
| Deni, I; Dhingra, SK; Eppstein, MJ; Fidock, DA; Gil-Iturbe, E; Hagenah, LM; Kim, J; Mancia, F; Mehta, M; Quick, M; Roepe, PD; Small-Saunders, JL; Vendome, J; Wicht, KJ | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Ye, R; Zhang, D; Zhang, Y | 1 |
| Boonyalai, N; Griesenbeck, JS; Kirativanich, K; Praditpol, C; Thamnurak, C; Vesely, BA; Waters, NC; Wojnarski, M | 1 |
| Attaher, O; Bousema, T; Bradley, J; Diallo, M; Dicko, A; Dicko, OM; Drakeley, C; Issiaka, D; Keita, S; Lanke, K; Maguiraga, SO; Mahamar, A; McCall, MBB; Niambele, SM; Sacko, A; Samake, S; Sanogo, K; Sinaba, Y; Smit, MJ; Stone, W; Ter Heine, R; Traore, SF | 1 |
| Siahaan, L | 1 |
| Campino, S; Clark, TG; Krishna, S; Last, A; Mańko, E; Moss, S | 1 |
| Bruschi, F; Fabiani, S; L'Episcopia, M; Mangano, V; Motta, V; Severini, C; Sparavelli, R; Verdenelli, S | 1 |
| Baro, B; Bassat, Q; Batty, KT; Karunajeewa, H; Laman, M; Manning, L; Millat-Martínez, P; Mitjà, O; Moore, BR; Page-Sharp, M; Pomat, W; Robinson, LJ; Salman, S | 1 |
| Abdallah, KS; Bacar, A; Deng, C; Li, G; Li, M; Liu, R; Lu, C; Silai, R; Song, J; Tan, R; Wu, W; Xu, Q; Yuan, Y; Zhang, H; Zheng, S | 1 |
| Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N | 1 |
| Fidock, DA; Hagenah, LM; Mok, S; Small-Saunders, JL; Wicht, KJ | 1 |
| Clapp, S; Freedman, B; Green, CL; Kirui, JK; Korwa, S; Njuguna, FM; O'Meara, WP; Taylor, SM; Wu, A | 1 |
| Albert, I; Bath, J; Fidock, DA; Koo, I; Llinás, M; Mok, S; Okombo, J; Orchard, LM; Owens, E; Qahash, T; Yeo, T | 1 |
| Assefa, A; Bekele, W; Chernet, M; Commons, RJ; Etana, K; Gidey, B; Girma, S; Gubae, K; Haile, M; Hailgiorgis, H; Mohammed, H; Sime, H; Solomon, H; Tasew, G; Tollera, G | 1 |
| Abera, A; Alemayehu, BH; Anand, A; Assefa, A; Bekele, W; Dilu, D; Etana, K; Ezema, B; Girma, S; Haile, M; Hwang, J; Minta, AA; Mohammed, H; Moriarty, LF; Murphy, M; Sime, H; Solomon, H; Svigel, SS; Tadesse, M; Tadesse, Y; Tasew, G; Teka, H; Woyessa, A; Zhou, Z | 1 |
| Barale, JC; Bouillon, A; Chy, S; Eam, R; Kauy, C; Ke, S; Khean, C; Khim, N; Kim, S; Kloeung, N; Kul, C; Leang, R; Mairet-Khedim, M; Ringwald, P; Roesch, C; Srun, S; Witkowski, B | 1 |
| Abuaku, B; Amoako, EO; Asamoah, A; Boateng, P; Duah-Quashie, NO; Koram, KA; Malm, KL; Matrevi, SA; Owusu-Antwi, F; Peprah, NY; Quashie, N | 1 |
| Akinola, O; Amusan, AI; Ategbero, E; Gbotosho, GO | 1 |
| Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K | 1 |
| Arcelia, F; Pasaribu, AP; Yanni, GN | 1 |
| Berger, F; D'Arrigo, G; Gomez, GM; Lanzer, M; Sanchez, CP; Wade, RC | 1 |
| Baraka, V; Francis, F; Geertruyden, JV; Gesase, S; Kyaruzi, E; Lusingu, JPA; Madebe, R; Makenga, G; Minja, DTR; Mtove, G; Nakato, S | 1 |
| Asih, PBS; Basri, HH; Bustos, MDG; Charunwatthana, P; Dewayanti, FK; Dondorp, AM; Imwong, M; Permana, DH; Prameswari, HD; Rahmasari, FV; Risandi, R; Rozi, IE; Syafruddin, D; Syahrani, L; Wangsamuda, S | 1 |
| Deng, DW; Li, M; Liu, H; Nie, RH; Wang, HY; Xu, JW; Yin, YJ | 1 |
| Benjamin, JM; Davis, TME; Kasian, B; Kong, C; Laman, M; Moore, BR; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, S; Tobe, R; Yadi, G | 1 |
| Banda, CG; Kalilani-Phiri, L; Khoo, SH; Lalloo, DG; Macuacua, S; Maculuve, S; Mallewa, J; Mukaka, M; Mwapasa, V; Piqueras, M; Sevene, E; Terlouw, DJ; Vala, A | 1 |
| Foguim Tsombeng, F; Gendrot, M; Madamet, M; Pradines, B; Robert, MG | 1 |
| Jiang, T; Krishna, S; Liao, FL; Tu, Y; Wang, J; Xu, C | 1 |
| Dhingra, SK; Fidock, DA; Ménard, D; Small-Saunders, JL | 1 |
| Blessborn, D; Byakika-Kibwika, P; Lamorde, M; Ssenyonga, R; Tarning, J | 1 |
| Burugu, M; Chege, W; Kimani, F; Matoke-Muhia, D; Muregi, F; Musyoka, KB; Nambati, EA; Omondi, P; Otinga, M; Thiongo, K; Too, E | 1 |
| Chibale, K; Fidock, DA; Goldberg, DE; Istvan, ES; Lee, MCS; Llinás, M; Murithi, JM; Ottilie, S; Owen, ES; Vanaerschot, M; Winzeler, EA | 1 |
| Aye, KH; Bustos, MD; Han, KT; Han, ZY; Lin, K; Markwalter, CF; Moe, M; Myint, MK; Nyunt, MM; Plowe, CV; Rahman, MM; Ringwald, P; Simmons, R; Thi, A | 1 |
| Beardmore, M; Bouchaud, O; Buffet, P; Lupoglazoff, JM; Michel, JF; Pull, L; Siriez, JY | 1 |
| Calçada, C; Ferreira, PE; Silva, M; Teixeira, M; Veiga, MI | 1 |
| Amalvict, R; Benoit, N; Chevalier, A; Delaunay, P; Fonta, I; Jeandel, PY; Madamet, M; Marty, P; Massamba, L; Mondain, V; Mosnier, J; Pomares, C; Pradines, B | 1 |
| Adhikari, B; Cheah, PY; Chotivanich, K; Cobelens, F; Davoeung, C; Day, NPJ; Dhorda, M; Dondorp, AM; Hanboonkunupakarn, B; Hien, TT; Imwong, M; Jittmala, P; Kajeechiwa, L; Landier, J; Lwin, KM; Mayxay, M; Mukaka, M; Newton, PN; Nguon, C; Nguyen, TN; Nosten, FH; Nosten, S; Parker, DM; Peerawaranun, P; Peto, TJ; Phommasone, K; Pongvongsa, T; Promnarate, C; Proux, S; Pukrittayakamee, S; Rekol, H; Thwaites, GE; Thwin, MM; Tripura, R; van Leth, F; von Seidlein, L; White, NJ; Wiladphaingern, J | 1 |
| Amaratunga, C; Amato, R; Anvikar, AR; Ashley, E; Baidya, S; Behera, PK; Callery, JJ; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NPJ; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, A; Fanello, C; Gantait, K; Ghosh, T; Gonçalves, S; Grobusch, MP; Hanboonkunupakarn, B; Heaton, J; Hien, TT; Hlaing, TM; Hoa, NT; Hoglund, RM; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Lin, K; Mao, S; Maude, RJ; Mayxay, M; Miotto, O; Mohanty, AK; Mukaka, M; Newton, PN; Onyamboko, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Pyae Phyo, A; Runcharern, R; Saelow, C; Satpathi, P; Satpathi, S; Smithuis, F; Sovann, Y; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thant, M; Thuy-Nhien, NT; Tripura, A; Tripura, R; Ul Islam, A; Valecha, N; van der Pluijm, RW; van Vugt, M; von Seidlein, L; Waithira, N; White, NJ; Winterberg, M; Woodrow, CJ; Yen, S | 1 |
| Fidock, DA; Hagenah, LM; Small-Saunders, JL | 1 |
| Abdulla, S; Adjei, A; Adjuik, M; Asante, KP; Baiden, R; Binka, F; Compaore, G; Day, NPJ; Gyapong, M; Kabanywanyi, AM; Macete, E; Oduro, A; Ogutu, B; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Tarning, J; Tinto, H; Valea, I; Wattanakul, T; White, NJ; Winterberg, M | 1 |
| Akakpo, S; Chalon, S; Chughlay, MF; Csermak-Renner, K; Djeriou, E; Gaur, AH; Leboulleux, D; McCarthy, J; Odedra, A; Shanks, GD; Winnips, C | 1 |
| Desai, MR; Hamel, MJ; Kachur, SP; Kariuki, S; Lindblade, KA; Odero, NA; Odongo, W; Otieno, K; Samuels, AM; Shi, YP; Williamson, J | 1 |
| Achan, J; Arinaitwe, E; Bigira, V; Dorsey, G; Gasasira, A; Havlir, D; Jagannathan, P; Kakuru, A; Kamya, MR; Kapisi, J; Muhindo, M; Nankabirwa, JI; Natureeba, P; Rek, J; Rodriguez-Barraquer, I; Rosenthal, PJ; Wanzira, H | 1 |
| Duong, NTT; Duong, TT; Erhart, A; Guetens, P; Hien, NTT; Hieu, NL; Huan, RM; Kattenberg, JH; Mai, TT; Ngoc, NTH; Phuc, BQ; Rosanas-Urgell, A; Rovira-Vallbona, E; Van Hong, N; Xa, NX | 1 |
| Badiane, AS; Dème, AB; Diallo, I; Diallo, MA; Dieye, B; Diongue, K; Gomis, JF; Ndiaye, D; Ndiaye, M; Ndiaye, YD; Seck, MC; Sow, D; Sy, M; Sy, SA; Yade, MS | 1 |
| Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
| Bah, S; Dabitao, D; Dama, S; Diakité, M; Diakité, SAS; Doumbia, S; Doumbouya, M; Guindo, MA; Keita, B; Konaté, DS; Sangaré, M; Sanogo, I; Traoré, K | 1 |
| Riegel, B; Roepe, PD | 1 |
| Chiyende, E; Chizema Kawesha, E; Earle, D; Eisele, TP; Finn, TP; Hamainza, B; Jennings, T; Miller, JM; Sikombe, C; Silumbe, K; Steketee, RW | 1 |
| Bennett, A; Bridges, DJ; Chishimba, S; Eisele, TP; Finn, TP; Hamainza, B; Lungu, C; Mambwe, B; Miller, JM; Mulube, C; Mwenda, MC; Porter, TR; Silumbe, K; Slutsker, L; Steketee, RW; Yukich, JO | 1 |
| Chizema Kawesha, E; Miller, JM; Steketee, RW | 1 |
| Bennett, A; Conner, RO; Eisele, TP; Finn, TP; Hamainza, B; Keating, J; Larson, BA; Miller, JM; Porter, TR; Scott, C; Silumbe, K; Steketee, RW; Yukich, JO | 1 |
| Bennett, A; Chalwe, V; Chizema Kawesha, E; Conner, RO; Earle, D; Eisele, TP; Finn, TP; Hamainza, B; Kamuliwo, M; Keating, J; Kooma, E; Miller, JM; Moonga, H; Porter, TR; Schneider, K; Silumbe, K; Slutsker, L; Steketee, RW; Yukich, JO | 1 |
| Bennett, A; Chalwe, V; Eisele, TP; Finn, TP; Hamainza, B; Keating, J; Kooma, E; Miller, JM; Moonga, H; Porter, TR; Silumbe, K; Steketee, RW; Yukich, JO | 1 |
| Bennett, A; Chizema Kawesha, E; Conner, RO; Eisele, TP; Finn, TP; Hamainza, B; Keating, J; Lungu, C; Miller, JM; Porter, TR; Silumbe, K; Steketee, RW; Yukich, JO | 1 |
| Chizema Kawesha, E; Eisele, TP; Fraser, MS; Lewis, MT; Miller, JM; Slutsker, L | 1 |
| Ba, A; Ba, M; Ba, S; Cissé, B; Cissé, M; Conner, RO; Dieye, Y; Diop, M; Doucouré, E; Earle, D; Faye, F; Guinot, P; Guinovart, C; Hainsworth, M; Schneider, K; Sene, D; Steketee, RW; Sy, MD; Tall, A; Thiam, T | 1 |
| Ategeka, J; Chandramohan, D; Clark, TD; Dorsey, G; Havlir, DV; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Nakalembe, M; Ochieng, T; Ochokoru, H; Roh, ME; Ruel, T; Staedke, SG | 1 |
| Bélard, S; Kurth, F; Ramharter, M | 1 |
| Ahmed, R; Asih, PBS; Chotsiri, P; Desai, M; Gutman, JR; Kariuki, S; Katana, A; Khairallah, C; L'lanziva, A; Otieno, K; Ouma, P; Poespoprodjo, JR; Price, RN; Syafruddin, D; Tarning, J; Ter Kuile, FO; Were, V | 1 |
| Badolo, O; Compaore, CS; Dao, B; Gansané, A; Kangoye, D; Kinda, R; Ménard, D; Moriarty, LF; Ouedraogo, E; Sondo, P; Soulama, E; Tapsoba, M; Tarama, C; Tchwenko, S; Tinto, H; Valea, I; Yerbanga, I | 1 |
| Baker, M; Hoglund, RM; McCarthy, JS; McWhinney, B; Mohrle, J; Tarning, J; Wattanakul, T | 1 |
| Adams, M; Boonyalai, N; Chaisatit, C; Chann, S; Chaorattanakawee, S; Deutsch-Feldman, M; Gosi, P; Lanteri, CA; Lek, D; Lertsethtakarn, P; Lin, JT; Lon, C; Morgan, AP; Praditpol, C; Rekol, H; Saingam, P; Satharath, P; Saunders, DL; Sea, D; Shah, Z; Shrestha, B; Smith, PL; Sok, S; Spring, MD; Takala-Harrison, S; Tyner, SD; Vesely, BA; Waters, NC; Wojnarski, M | 1 |
| Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C | 1 |
| Assefa, DG; Bekele, D; Getachew, E; Joseph, M; Manyazewal, T; Tesfahunei, HA; Zeleke, ED | 1 |
| Bouchaud, O; Jullien, V; Pull, L; Siriez, JY; Tielli, A | 1 |
| Angheben, A; Bacchieri, A; Bardají, A; Behrens, RH; Bisoffi, Z; Bottieau, E; Bouchaud, O; Bourhis, Y; Calleri, G; Duparc, S; Hatz, C; Iannucelli, M; Jelinek, T; Martin, C; Mattera, GG; Mechain, M; Merlo Pich, E; Nothdurft, HD; Ramos, JM; Rapp, C; Rojo-Marcos, G; Salas-Coronas, J; Tommasini, S; Velasco, M; Vignier, N; Visser, LG | 1 |
| Achan, J; Bah, A; Balen, J; Bradley, J; D'Alessandro, U; Dabira, E; Drammeh, NF; Jaiteh, F; Masunaga, Y; Mohammed, N; Muela Ribera, J; Okebe, J; Peeters Grietens, K; Yeung, S | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Bassat, Q; Varo, R | 1 |
| Bejon, P; Boga, M; Day, NPJ; Dhorda, M; Dondorp, AM; Gonçalves, S; Hamaluba, M; Hoglund, RM; Imwong, M; Kalume, P; Khuroo, A; Lal, AA; Miotto, O; Mturi, N; Mukaka, M; Mutinda, B; Mwambingu, G; Ngama, M; Ngetsa, C; Njuguna, P; Tarning, J; Taylor, WRJ; van der Pluijm, RW; Waithira, N; Wambua, J; Weya, J; White, NJ | 1 |
| Ashley, EA; Aung, H; Aung, Y; Day, NPJ; Dondorp, AM; Heaton, J; Hlaing, T; Imwong, M; Indrasuta, C; Khant, ZS; Kyaw, TT; Maung, SM; McLean, ARD; Phyo, AK; Smithuis, FM; Soe, K; Swe, MMM; Tun, KM; Tun, NN; von Seidlein, L; White, NJ | 1 |
| Arsanok, M; Boonyalai, N; Chaisatit, C; Chaorattanakawee, S; Chattrakarn, S; Fagnark, W; Fukuda, MM; Gaywee, J; Gosi, P; Jongsakul, K; Kirativanich, K; Kuntawunginn, W; Lanteri, C; Lertsethtakarn, P; Praditpol, C; Rodkvamtook, W; Sai-Ngam, P; Saunders, DL; Sirisopana, N; Smith, PL; Spring, MD; Sundrakes, S; Ta-Aksorn, W; Thamnurak, C; Utainnam, D; Uthaimongkol, N; Vanachayangkul, P; Vesely, BA; Walsh, D; Waters, NC; Wojnarski, M | 1 |
| Anstey, NM; Apriyanti, D; Auburn, S; Brockman, A; Chalfein, F; Kenangalem, E; Leonardo, L; Luo, I; MacHunter, B; Marfurt, J; Noviyanti, R; Piera, KA; Poespoprodjo, JR; Prayoga, P; Price, RN; Rumaseb, A; Russell, B; Sebayang, BF; Sihombing, MAEM; Suwanarusk, R; Trianty, L; Wirjanata, G | 1 |
| Hirai, M; Ikeda, M; Mita, T; Mori, T; Tachibana, SI | 1 |
| Chien, HD; Kesely, KR; Low, PS; Noomuna, P; Pantaleo, A; Putt, KS; Tuan, TA; Turrini, FM | 1 |
| Abega, F; Ayong, L; Berry, A; Gandia, P; Iriart, X; Khim, N; Lanot, T; Mairet-Khedim, M; Menard, S; Morlais, I; Ngou, C; Nsango, S; Otam, L; Roesch, C; Srun, S; Witkowski, B | 1 |
| Bustos, D; Dong, LT; Duong, TT; Galappaththy, GL; Loi, MA; Ménard, D; Phuc, BQ; Rasmussen, C; Ringwald, P; Tarning, J; Thieu, NQ | 1 |
| Adjei, A; Adjuik, M; Baiden, R; Binka, F; Gyapong, M; Oduro, AR; Osei, I; Owusu-Agyei, S; Sobe, E; Yawson, A | 1 |
| Abdel Hamid, MM; Adam, MA; Elkando, NS; Elnour, FAA; Malik, EM; Mohamed, AO; Mohamed, OS; Suliman, A | 1 |
| Combrinck, JM; Cooper, RA; Cowell, AN; Dhingra, SK; Egan, TJ; Fidock, DA; Gupta, P; Henrich, PP; Hoke, JM; Mok, S; Okombo, J; Redhi, D; Stegman, ML; Winzeler, E; Yeo, T | 1 |
| Dixon, MW; Farid, R; McCarthy, JS; Tilley, L | 1 |
| Nosten, F | 1 |
| Clark, RL | 1 |
| Bailey, JA; Barnett, EJ; Brazeau, NF; Chaorattanakawee, S; Gosi, P; Juliano, JJ; Lanteri, CA; Lin, JT; Lon, C; Meshnick, SR; Norris, LD; Parobek, CM; Parr, JB; Saunders, DL; Spring, MD | 1 |
| Byaruhanga, O; Ceja, FG; Conrad, MD; Cooper, RA; Katairo, T; Nsobya, SL; Rasmussen, SA; Rosenthal, PJ; Tumwebaze, PK | 1 |
| Aweeka, F; Conrad, MD; Dorsey, G; Foster, M; Havlir, DV; Huang, L; Jagannathan, P; Kakuru, A; Kamya, MR; Legac, J; Mota, D; Nayebare, P; Rosenthal, PJ; Tukwasibwe, S; Tumwebaze, P; Wallender, E; Whalen, M | 1 |
| Adamy, M; Adoke, Y; Bassat, Q; Biguenet, S; Bouyou-Akotet, M; Demarest, H; Duong, TT; Duparc, S; Foster, C; Issifou, S; Kibuuka, A; Kremsner, PG; Laurijssens, BE; Leipoldt, I; Leroy, D; Macintyre, F; Mombo-Ngoma, G; Ouedraogo, A; Phuc, BQ; Ramharter, M; Smith, M; Tinto, H; Tiono, AB; Tshefu, AK | 1 |
| Anvikar, AR; Behra, N; Das, RR; Gaye, O; Jalali, RK; Maheshwar, AV; Mishra, P; Mwapasa, V; Nasa, A; Roy, A; Sagara, I; Sharma, P; Sharma, SK; Thompson, R; Toure, OA; Tshefu, AK; Valecha, N | 1 |
| Roberts, L | 1 |
| Bassat, Q; D'Alessandro, U; Gargano, N; Gesase, S; Halidou, T; Madrid, L; Mtoro, A; Sirima, S; Tshefu, A; Valentini, G | 1 |
| Bridges, DJ; Chalwe, V; Hamainza, B; Larsen, DA; Miller, JM; Moonga, H; Nyangu, J; Silumbe, K; Steketee, R | 1 |
| Day, NPJ; Dondorp, AM; Hien, TT; Le Phuc-Nhi, T; Phu, NT; Son, DH; Thuy-Nhien, N; Thwaites, GE; Tran, NH; Tuyen, NTK; Van Dung, N; Van Quan, B; von Seidlein, L; White, NJ | 1 |
| Arie, S | 1 |
| Adewoye, EO; Agomo, C; Akano, K; Ambe, J; Ayede, AI; Ebenebe, J; Emechebe, G; Ezeigwe, N; Fatunmbi, B; Finomo, F; Folarin, OA; Gbotosho, GO; Happi, CT; Jiya, N; Mokuolu, O; Ntadom, G; Oguche, S; Oyibo, WA; Sowunmi, A; Useh, F; Wammanda, R; Wewe, OA | 1 |
| Aweeka, F; Dorsey, G; Havlir, D; Huang, L; Jagannathan, P; Kakuru, A; Kamya, M; Muhindo, M; Nakalembe, M; Natureeba, P; Rosenthal, PJ; Savic, RM; Vucicevic, K; Wallender, E | 1 |
| Kadia, BM; Morfaw, C; Simo, ACG | 1 |
| Adegnika, AA; Cattaneo, C; Duparc, S; Endamne, L; Flohr, L; Groger, M; Hutchinson, D; Kabwende, L; Kim, J; Kremsner, PG; Lell, B; Lötsch, F; Mischlinger, J; Moehrle, J; Mombo-Ngoma, G; Mordmüller, B; Nguyen, TT; Ramharter, M; Remppis, J; Sievers, M; Velavan, TP; Veletzky, L; Zoleko Manego, R | 1 |
| Abello Peiri, C; De Smet, M; Debackere, M; Eam, R; Ken, M; Khean, C; Khim, N; Kim, S; Kindermans, JM; Menard, D; Nguon, C; Rossi, G; Van den Bergh, R; Van, V; Vernaeve, L | 1 |
| Dama, S; de Smet, M; Djimdé, A; Doumbo, OK; Etard, JF; Grandesso, F; Guindo, O; Laminou, IM; Makarimi, R; Ouwe Missi Oukem-Boyer, O; Rigal, J; Traore, A; Woi Messe, L | 1 |
| Adams, M; Bousema, T; Chalon, S; Collins, KA; Elliott, S; McCarthy, JS; Mitchell, H; Möhrle, JJ; Rampton, M; Reuling, IJ; Sauerwein, R; Wang, CY | 1 |
| Bousema, T; Bradley, J; Brown, JM; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Hwang, J; Issiaka, D; Keita, S; Kone, DT; Lanke, K; Mahamar, A; McCulloch, C; Müller, O; Roh, ME; Sanogo, K; Soumare, HM; Srinivasan, V; Stone, WJR; Traore, SF | 1 |
| Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K | 1 |
| Chan, D; Chea, N; Day, NPJ; Dhorda, M; Dondorp, AM; Duanguppama, J; Grobusch, MP; Huy, R; Imwong, M; Mukaka, M; Patumrat, K; Peto, TJ; Promnarate, C; Sirithiranont, P; Tripura, R; von Seidlein, L; White, NJ | 1 |
| Aweeka, FT; Clark, TD; Dorsey, G; Havlir, DV; Huang, L; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, M; Muhindo, MK; Mwebaza, N; Opira, B; Rosenthal, PJ; Savic, RM; Wallender, E; Were, M; Zhang, N | 1 |
| Andrade, BN; Davlantes, E; Dimbu, PR; Dos Santos Souza, S; Félix, J; Ferreira, CM; Florinda Joao, M; Fortes, F; Halsey, ES; Martins, JF; Mbounga, E; Owens, C; Plucinski, MM; Pode, D; Sanhangala, E; Talundzic, E; Udhayakumar, V; Wiesner, L | 1 |
| Anh, CX; Birrell, GW; Chavchich, M; Edstein, MD; Quang, NN; Rowcliffe, K; Travers, T; van Breda, K | 1 |
| Banda, RL; Fulakeza, JRM; Hodel, EM; Lipenga, TR; Nkhoma, SC; Terlouw, DJ | 1 |
| Björkman, A; Djimde, A; Ferreira, PE; Fofana, B; Gil, JP; Inoue, J; Mårtensson, A; Sagara, I; Sanogo, K; Silva, M; Veiga, MI | 1 |
| Bacar, A; Deng, C; Fay, MP; Feng, D; Huang, B; Huang, S; Kéké, RA; Li, D; Li, G; Li, XB; Lin, L; Liu, XH; Lu, F; Mohadji, F; Mohamed, M; Msa Mliva, A; Oithik, F; Said Abdallah, K; Song, J; Su, XZ; Tuo, F; Wang, Q; Wang, X; Wellems, TE; Wu, W; Wu, Z; Xu, Q; Xue, L; Yan, H; Yang, T; Zhang, H; Zheng, S; Zhou, J | 1 |
| Abdulkadir, M; Aderoyeje, T; Agomo, C; Akano, K; Ambe, J; Ebenebe, JC; Emechebe, G; Ezeigwe, NM; Finomo, F; Folarin, OA; Happi, C; Jiya, N; Mokuolu, O; Ntadom, G; Oguche, S; Oyibo, W; Sowunmi, A; Useh, F; Wammanda, R | 1 |
| Dongho, BGD; L'Episcopia, M; Lucchi, NW; Menegon, M; Russo, G; Severini, C; Souza, SS; Vullo, V | 1 |
| Gesase, S; Ishengoma, DS; Kavishe, RA; Lemnge, MM; Mandara, CI; Mandike, R; Mghamba, J; Mkude, S; Mmbuji, P; Mohamed, A; Ngadaya, E; Njau, R; Warsame, M | 1 |
| Aweeka, F; Beeson, J; Charlebois, ED; Clark, TD; Dorsey, G; Drakeley, C; Feeney, ME; Greenhouse, B; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, MK; Nakalembe, M; Nankya, F; Natureeba, P; Okiring, J; Olwoch, P; Opira, B; Prahl, M; Reiling, L; Rodriguez-Barraquer, I; Ssewanyana, I; Tetteh, K; Wallender, E | 1 |
| Ariey, F; Dhingra, SK; Fairhurst, RM; Fidock, DA; Kümpornsin, K; Menard, D; Mok, S; Ross, LS; Takala-Harrison, S; Wicht, KJ; Witkowski, B; Yeo, T | 1 |
| Cao, P; Dini, S; Fowkes, FJI; McCaw, JM; Price, RN; Simpson, JA; van der Pluijm, RW; Zaloumis, S | 1 |
| Amalvict, R; Benoit, N; Foguim Tsombeng, F; Gendrot, M; Mosnier, J; Pradines, B; Robert, MG; Torrentino-Madamet, M | 1 |
| Cao, P; Cromer, D; Davenport, MP; Dini, S; Fowkes, FJI; Khoury, DS; McCaw, JM; Simpson, JA; Zaloumis, SG | 1 |
| Abel, H; Bassat, Q; Ila, R; Karunajeewa, H; Laman, M; Manning, L; Millat-Martínez, P; Mitjà, O; Moore, B; Pulai, K; Robinson, L; Sanz, S | 1 |
| Dama, S; Dara, A; Djimde, AA; Djimde, M; Doumbo, OK; Guindo, CO; Niangaly, H; Sagara, I; Zeguime, A | 1 |
| Hetzel, MW; Karl, S; Kattenberg, JH; Kiniboro, B; Laman, M; Makita, L; Mueller, I; Oswyn, G; Pulford, J; Rare, L; Robinson, L; Siba, PM; Tavul, L; Teliki, A; Walsh, D | 1 |
| Chann, S; Fukuda, MM; Gosi, P; Kuntawunginn, W; Lin, J; Lon, C; Manning, J; Rekol, H; Satharath, P; Saunders, D; Sinoun, M; Smith, PL; So, M; Somethy, S; Soveasna, K; Spring, M; Sriwichai, S; Wojnarski, M | 1 |
| Bartalesi, F; Bartolesi, AM; Bartoloni, A; Berni, A; Boccolini, D; Buonamici, C; Ciccone, N; Corti, G; Di Lauria, N; Garofalo, G; Gradoni, L; Mencarini, J; Niccolini, F; Poggesi, L; Romi, R; Rossolini, GM; Severini, C; Suardi, LR; Zammarchi, L | 1 |
| Chacky, F; Ishengoma, DS; Kabanywanyi, AM; Kakolwa, MA; Kamugisha, E; Kataraihya, JB; Lemnge, MM; Mahende, MK; Mandara, CI; Mandike, R; Menard, D; Mkude, S; Ngasala, B; Njau, R; Premji, Z; Warsame, M | 1 |
| Adhikari, B; Chotivanich, K; Day, NPJ; Dondorp, AM; Hanboonkunupakarn, B; Henriques, G; Imwong, M; Mayxay, M; Mukaka, M; Newton, PN; Peerawaranun, P; Phommasone, K; Pongvongsa, T; Pukrittayakamee, S; Singhasivanon, P; von Seidlein, L; White, NJ | 1 |
| Bosco, A; Conrad, M; Kalyesubula, S; Kibuuka, A; Kigozi, R; Kyambadde, P; Mulebeke, R; Opigo, J; Rosenthal, PJ; Senzoga, J; Vinden, J; Wallender, E; Yeka, A | 1 |
| Boxberger, M; Gaillard, T; Madamet, M; Pradines, B | 1 |
| Asua, V; Conrad, MD; Dorsey, G; Kamya, MR; Kigozi, SP; Legac, J; Nsobya, SL; Rosenthal, PJ; Vinden, J | 1 |
| Birrell, GW; Chavchich, M; Chuang, I; Edstein, MD; Manh, ND; Martin, NJ; Phong, NC; Quang, HH; San, NN | 1 |
| Chandramohan, D; Chotsiri, P; Compaore, YD; Greenwood, B; Hanpithakpong, W; Milligan, P; Nosten, F; Ouédraogo, JB; Rosenthal, PJ; Somé, AF; Tarning, J; White, NJ; Zongo, I | 1 |
| Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
| Amalvict, R; Benoit, N; Bercion, R; Diatta, B; Diawara, S; Fall, B; Fall, M; Foguim Tsombeng, F; Gendrot, M; Gueye, MW; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Robert, MG; Wade, B; Wade, KA | 1 |
| Cantinieaux, B; Genderini, FG; Haeseleer, C; Martin, C | 1 |
| Chacky, F; Chiduo, MG; Francis, F; Ishengoma, DS; Mandara, CI; Mandike, R; Mkude, S; Mohamed, A; Molteni, F; Ngasala, B; Njau, R; Warsame, M | 1 |
| Ategeka, J; Clark, TD; Dorsey, G; Havlir, DV; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Nakalembe, M; Nayebare, P; Ochieng, T; Ochokoru, H; Opira, B; Ruel, T | 1 |
| Adoke, Y; Barry, A; Dossou, Y; Duong, TT; Khim, N; Klopper, R; Laurijssens, B; Legrand, E; Leroy, D; Macintyre, F; Ménard, D; Mombo-Ngoma, G; Ndong Ngomo, JM; Ouoba, S; Phuc, BQ; Tshefu, AK; Varo, R | 1 |
| Buffet, C; Karahalios, A; Khairallah, C; Kuile, FOT; Madanitsa, M; Mwapasa, V; Narum, DL; Phiri, LK; Randall, LM; Rogerson, SJ; Teo, A | 1 |
| Deng, C; Huang, B; Liang, Y; Song, J; Su, Y; Tan, B; Wang, Q; Wu, G; Wu, W; Zhang, H; Zhang, Z; Zhou, C | 1 |
| Aweeka, FT; Chamankhah, N; Dorsey, G; Huang, L; Jagannathan, P; Kajubi, R; Kamya, MR; Mwebaza, N; Orukan, F; Rosenthal, PJ; Wallender, E; Whalen, ME | 1 |
| Abdulrahman, A; Amran, JGH; Arale, AM; Gomey, AH; Hassan, AH; Hassan, AM; Jibril, AM; Khim, N; Mohamed, MS; Nur, ZS; Osman, SM; Ringwald, P; Warsame, M; Witkowski, B; Yusuf, FE | 1 |
| Charlebois, E; Clark, TD; Dorsey, G; Feeney, ME; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, MK; Nalugo, N; Okiring, J; Olwoch, P; Opira, B; Ruel, T | 1 |
| Chy, S; Felger, I; Hastings, I; Hodel, EM; Jones, S; Kay, K; Mbituyumuremyi, A; Menard, D; Uwimana, A | 1 |
| Amaratunga, C; Amato, R; Chan, XHS; Chau, NH; Chindavongsa, K; Day, NP; Dhorda, M; Dondorp, AM; Drury, E; Dysoley, L; Fairhurst, RM; Gonçalves, S; Hamilton, WL; Hanboonkunupakarn, B; Hien, TT; Hongvanthong, B; Huch, C; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kwiatkowski, DP; Leang, R; Maude, RJ; Mayxay, M; Miotto, O; Nguyen, T; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Quang, HH; Rockett, K; Sovann, Y; Suon, S; Thuy-Nhien, NT; Tripura, R; van der Pluijm, RW; Vongpromek, R; White, NJ | 1 |
| Amaratunga, C; Amato, R; Ashley, EA; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NP; Dhorda, M; Dondorp, AM; Fairhurst, RM; Gonçalves, S; Hamilton, WL; Hanboonkunupakarn, B; Hien, TT; Hoa, NT; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Mao, S; Maude, RJ; Miotto, O; Mukaka, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Runjarern, R; Saelow, C; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thuy-Nhien, NT; Tripura, R; van der Pluijm, RW; Waithira, N; White, NJ; Winterberg, M; Yen, S; Yok, S | 1 |
| Adams, ER; Ahmed, R; Asih, PBS; Chen, T; Faragher, B; Khairallah, C; Lukito, T; Maratina, SS; Pace, C; Poespoprodjo, JR; Price, RN; Santana-Morales, MA; Smedley, J; Syafruddin, D; Ter Kuile, FO; Unwin, VT; Wang, D; Williams, CT | 1 |
| Price, RN | 1 |
| Baidjoe, AY; Beshir, KB; Bousema, T; Drakeley, CJ; Hallett, RL; Hermsen, CC; Kavishe, RA; Manjurano, A; Mweresa, CK; Okell, L; Omar, SA; Sauerwein, RW; Sawa, P; Schallig, HD; Shekalaghe, SA; Sutherland, CJ; Yussuf, RU | 1 |
| Arzika, I; Fandeur, T; Guillebaud, J; Issaka, M; Maazou, A; Salissou, A; Specht, S; Zamanka, H | 1 |
| Agarwal, A; Desai, M; Kachur, SP; Kariuki, S; McMorrow, M; Odero, C; Onyango, P; Otieno, K; Slutsker, L; Williamson, J | 1 |
| Amaratunga, C; Anderson, JM; Ashley, EA; Char, MC; Chy, S; Dek, D; Dondorp, AM; Eastman, RT; Fairhurst, RM; Lim, P; Mao, S; Menard, D; Miotto, O; Sam, B; Sopha, C; Sreng, S; Su, XZ; Suon, S; Try, V; White, NJ | 1 |
| Beshir, KB; Bousema, T; Chilongola, J; Drakeley, CJ; Hallett, RL; Kaur, H; Mweresa, CK; Ndaro, A; Okell, L; Omar, SA; Sauerwein, RW; Sawa, P; Schallig, HD; Shekalaghe, SA; Sutherland, CJ | 1 |
| Bellettre, X; Bouchaud, O; Michel, JF; Pull, L; Siriez, JY | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Abiola, A; Faye, B; Folly, K; Gaye, O; Lo, AC; Ndiaye, JL; Ndiaye, LA; Ndiaye, M; Sow, D; Sylla, K; Tine, RC | 1 |
| Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B | 1 |
| Annerberg, A; Ashley, E; Day, NP; Kiricharoen, L; Lindegardh, N; Lwin, KM; Nosten, F; Tarning, J; White, NJ | 1 |
| Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Arinaitwe, E; Dorsey, G; Jagannathan, P; Kaharuza, F; Kakuru, A; Kamya, MR; Muhindo, MK; Orukan, F; Osilo, E; Talisuna, A; Tappero, JW | 1 |
| Akhwale, W; Eyase, F; Johnson, JD; Juma, E; Koskei, N; Obonyo, C; Ogutu, BR; Omollo, R; Omondi, EK; Ongecha, JM; Onyango, KO; Otieno, GA; Otieno, L; Perkins, DJ | 1 |
| Amuge, P; Brooker, SJ; Dorsey, G; Kamya, MR; Kiwanuka, N; Nankabirwa, JI; Rosenthal, PJ; Staedke, SG; Wandera, B | 1 |
| Chen, K; Cui, L; Fan, Q; Feng, G; Hao, M; Lin, Y; Sun, L; Wu, Y; Yang, Z; Zhao, Z | 1 |
| Bethell, D; Buathong, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Juliano, JJ; Kaewkungwal, J; Kuntawunginn, W; Lanteri, C; Lin, J; Lon, C; Manning, JE; Nou, S; Satharath, P; Saunders, D; Se, Y; Sea, D; So, M; Spring, M; Sriwichai, S; Tang, D; Tyner, SD; Vanachayangkul, P; Walsh, DS | 1 |
| Arinaitwe, E; Bigira, V; Conrad, M; Dorsey, G; Kakuru, A; Kamya, MR; Muhindo, MK; Rosenthal, PJ; Tappero, JW; Wanzira, H | 1 |
| Deng, Y; Lasi, JH; Sun, XD; Sun, XY; Wang, H; Wang, J; Yang, YC; Zhang, ZX | 1 |
| Cheah, PY; Day, NP; Dondorp, AM; Fanello, CI; Nosten, F; Onyamboko, MA; Tarning, J; Tshefu, KA; White, NJ; Wongsaen, K | 1 |
| Lon, C; Saunders, DL; Vanachayangkul, P | 1 |
| Lindegardh, N; Nosten, F; Ouédraogo, JB; Parikh, S; Rosenthal, PJ; Rouamba, N; Somda, SA; Somé, FA; Tarning, J; Zongo, I | 1 |
| Amambua-Ngwa, A; D'Alessandro, U; Duong, TT; Erhart, A; Guetens, P; Ha, do M; Hong, NV; Phuc, BQ; Pockele, E; Rosanas-Urgell, A; Thriemer, K; Van, NV | 1 |
| Dahlstrom, S; Ferreira, PE; Franzén, O; Gil, JP; Lum, JK; Nosten, F; Osório, NS; Veiga, MI | 1 |
| Dimbu, PR; Fortes, F; Goldman, I; Lucchi, N; Macaia, AP; MacArthur, JR; Morton, L; Plucinski, MM; Stennies, G; Talundzic, E; Udhayakumar, V | 1 |
| Baraka, V; D'Alessandro, U; Delgado-Ratto, C; Erhart, A; Fitzhenry, R; Mbonye, MK; Rosanas-Urgell, A; Tinto, H; Valea, I; Van Geertruyden, JP; Van Overmeir, C | 1 |
| Baker, M; Bousema, T; Cairns, M; D'Alessandro, U; Ferguson, NM; Ghani, AC; Griffin, JT; Hugo, P; Jagoe, G; Okell, LC; Tarning, J; Ubben, D | 1 |
| Ali, IM; Chedjou, JP; Ekollo, AM; Evehe, MS; Froeschl, G; Heumann, C; Mansmann, U; Mbacham, WF; Moyeh, MN; Ndikum, VN; Ngongang, EO; Nji, AM; Ogundahunsi, O | 1 |
| Guo, XR; Huang, F; Li, CF; Li, M; Li, XL; Lin, YX; Liu, H; Nie, RH; Tang, LH; Wang, HY; Wang, J; Wang, JZ; Xu, JW; Yang, HL | 1 |
| Gathu, M; Isba, R; Sinclair, D; Zani, B | 1 |
| Amalvict, R; Benoit, N; Briolant, S; Gaillard, T; Madamet, M; Pascual, A; Pradines, B; Travers, D | 1 |
| Arsanok, M; Balasubramanian, S; Buathong, N; Bun, R; Chanarat, N; Chann, S; Chaorattanakawee, S; Chour, CM; Gosi, P; Heng, TK; Ittiverakul, M; Juliano, JJ; Kong, N; Kuntawunginn, W; Lanteri, CA; Lin, JT; Lon, C; Manning, JE; Meshnick, SR; Nou, S; Phann, ST; Pichyangkul, S; Prom, S; Saunders, DL; Se, Y; Sia-ngam, P; Somethy, S; Spring, MD; Sundrakes, S; Ta-aksorn, W; Teja-isavadharm, P; Vanachayangkul, P | 1 |
| Eckhoff, P; Gerardin, J; Wenger, EA | 1 |
| Batty, KT; Benjamin, JM; Davis, TM; Lorry, L; Moore, BR; Mueller, I; Page-Sharp, M; Robinson, LJ; Salman, S; Siba, PM; Tawat, S; Yadi, G | 1 |
| Buathong, N; Chanarat, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Heng, TK; Jacob, C; Kong, N; Kuntawunginn, W; Lanteri, CA; Lin, JT; Lon, C; Plowe, C; Prom, S; Saingam, P; Saunders, DL; Se, Y; Sea, D; Sriwichai, S; Sundrakes, S; Takala-Harrison, S; Tangthongchaiwiriya, K; Teja-Isavadharm, P; Tyner, SD; Yingyuen, K; Yom, Y | 1 |
| Bouth, DM; Char, MC; Domergue, A; Duru, V; Khim, N; Kim, S; Leang, R; Menard, D; Ringwald, P; Song, L; Tarning, J; Taylor, WR; Witkowski, B | 1 |
| Hastings, IM; Kay, K | 1 |
| Hastings, IM; Hodel, EM; Kay, K | 1 |
| Bassat, Q; Borrmann, S; Mulenga, M; Pfeil, J; Talisuna, A; Tozan, Y | 1 |
| Cao, Y; Cui, L; Fan, Q; Lee, MC; Parker, D; Wang, Y; Xiao, Y; Yan, G; Yang, Z; Yuan, L; Zhou, G | 1 |
| Fairhurst, RM | 1 |
| Brashear, A; Cabrera, M; Cui, L; Gupta, B; Hu, Y; Kemirembe, K; Li, X; Liang, X; Miao, J; Shrestha, S; Sun, X; Wang, Y; Wang, Z; Wu, Y; Yang, Z; Zhang, Y | 1 |
| d'Alessandro, U; Dahal, P; Dorsey, G; Guerin, PJ; Nsanzabana, C; Price, RN; Sibley, CH; Stepniewska, K; Talisuna, AO | 1 |
| Baird, JK; Boni, MF; Dondorp, AM; Farrar, J; Lam, HM; Nguyen, TD; Olliaro, P; Thwaites, GE; White, NJ | 1 |
| Anvikar, AR; Arora, S; Iyer, SS; Jalali, RK; Mishra, P; Rao, BS; Roy, A; Rulisa, S; Saha, N; Sharma, P; Toure, OA; Valecha, N | 1 |
| Auma, A; Bigira, V; Bowen, K; Boyle, MJ; Dorsey, G; Farrington, LA; Feeney, ME; Jagannathan, P; Kamya, MR; Kapisi, J; McIntyre, TI; Nalubega, M; Naluwu, K; Nankya, F; Sikyomu, E; Vance, HM; Wamala, S | 1 |
| Ariey, F; Beghain, J; Chy, S; Domergue, A; Duru, V; Eam, R; Guerin, PJ; Huy, R; Ke, S; Ken, M; Khean, C; Khim, N; Kim, S; Kloeung, N; Leang, R; Lek, D; Loch, K; Menard, D; Mercereau-Puijalon, O; Witkowski, B | 1 |
| Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Gregory, C; Ittiverakul, M; Kuntawunginn, W; Lanteri, C; Lon, C; Prom, S; Saunders, DL; Somethy, S; Spring, MD | 1 |
| Amaratunga, C; Amato, R; Anderson, JM; Blessborn, D; Dek, D; Fairhurst, RM; Fay, MP; Lim, P; Mao, S; Sam, B; Song, L; Sopha, C; Sreng, S; Suon, S; Tarning, J; Try, V; Tullo, GS | 1 |
| Auyeung, SO; Batty, KT; Benjamin, JM; Davis, TM; Griffin, S; Moore, BR; Mueller, I; Page-Sharp, M; Rogerson, SJ; Salman, S; Siba, PM; Yadi, G | 1 |
| Baber, I; Bousema, T; Brown, JM; Chen, I; Diawara, H; Dicko, A; Gosling, R; Hwang, J; Keita, S; Koita, F; Lanke, K; Mahamar, A; McCulloch, C; Niemi, M; Nosten, F; Pett, H; Poirot, E; Sanogo, K; Soumare, HM; Traore, SF | 1 |
| Anvikar, AR; Arora, S; Bose, TK; Enosse, S; Gaye, O; Iyer, SS; Jalali, RK; Jha, AC; Kokolomami, J; Krudsood, S; Mohanty, R; Mohanty, S; Mwapasa, V; Ndiaye, JL; Noedl, H; Nyirenda, M; Rao, BHK; Rao, BS; Rao, D; Roy, A; Sagara, I; Saha, N; Sharma, P; Sidibe, B; Starzengruber, P; Swoboda, P; Tangpukdee, N; Thompson, R; Tiacoh, L; Toure, OA; Tshefu, AK; Valecha, N; Yumva, NN | 1 |
| Maxmen, A | 1 |
| Ashley, EA; Aung, SS; Day, NP; Dhorda, M; Dondorp, AM; Hlaing, TM; Imwong, M; Jeeyapant, A; Promnarate, C; Smithuis, FM; Thein, M; Tun, KM; White, NJ; Woodrow, CJ; Yuentrakul, P | 1 |
| Auma, A; Aweeka, F; Bigira, V; Bowen, K; Boyle, MJ; Dorsey, G; Farrington, LA; Feeney, ME; Greenhouse, B; Jagannathan, P; Kamya, M; Kapisi, J; McIntyre, TI; Nalubega, M; Naluwu, K; Nankya, F; Sikyomu, E; Wamala, S | 1 |
| Bass, JK; Bigira, V; Boivin, MJ; Dorsey, G; Familiar-Lopez, I; Kamya, M; Kapisi, J; Muhindo, M; Nakasujja, N; Opoka, RO; Ruiseñor-Escudero, H; Sikorskii, A | 1 |
| Domergue, A; Duru, V; Khim, N; Kim, S; Menard, D; Witkowski, B | 1 |
| Aubry, P; Gaüzère, BA; Ouledi, A; Toyb, M | 1 |
| Arinaitwe, E; Parikh, S; Sambol, NC; Tappero, JW | 1 |
| Aderoyeje, T; Adewoye, EO; Akano, K; Ayede, AI; Fatunmbi, B; Ntadom, G; Sowunmi, A | 1 |
| Brooker, SJ; Conrad, MD; Dorsey, G; Kamya, MR; Legac, J; Nankabirwa, JI; Nsobya, SL; Rosenthal, PJ; Staedke, SG; Tukwasibwe, S; Tumwebaze, P; Wandera, B | 1 |
| Bélard, S; Damm, G; Kim, J; Kurth, F; Lingscheid, T; Mayer, B; Menner, N; Pongratz, P; Salama, A; Seehofer, D; Stegemann, MS; Steiner, F; Suttorp, N; von Bernuth, H; Zoller, T | 1 |
| De Smet, M; Dondorp, A; Etienne, W; Falq, G; Imwong, M; Kindermans, JM; Nguon, C; Rekol, H; Van Den Bergh, R | 1 |
| Javelle, E; Madamet, M; Paleiron, N; Pradines, B; Roseau, JB; Simon, F; Vedy, S | 1 |
| Kofoed, PE; Rodrigues, A; Rombo, L; Ursing, J | 1 |
| Angheben, A; Bisoffi, Z; Buonfrate, D; Gobbi, F; Gori, S; Lunardi, G; Menegon, M; Severini, C | 1 |
| Dondorp, AM | 1 |
| Ariey, F; Barale, JC; Beghain, J; Bouchier, C; Bouillon, A; Chy, S; Domergue, A; Duru, V; Eam, R; Fidock, DA; Huy, R; Ke, S; Ken, M; Khean, C; Khim, N; Kim, S; Kloeung, N; Leang, R; Legrand, E; Loch, K; Ma, L; Ménard, D; Mercereau-Puijalon, O; Nuel, G; Ringwald, P; Ross, LS; Saintpierre, B; Witkowski, B | 1 |
| Anstey, NM; Burdarm, L; Devine, A; Karyana, M; Kenangalem, E; Poespoprodjo, JR; Price, RN; Tjitra, E; Vemuri, R; Yeung, S | 1 |
| Affara, M; Badji, H; Bousema, T; Correa, S; D'Alessandro, U; Dabira, E; Di Tanna, GL; Drakeley, C; Gaye, A; Nwakanma, D; Okebe, J; Sanya-Isijola, F; Van Geertruyden, JP | 1 |
| Bassat, Q; Menéndez, C | 1 |
| Abate, L; Abega Mekongo, FA; Awono-Ambéné, PH; Berry, A; Iriart, X; Maffo, CN; Menard, S; Morlais, I; Nsango, SE; Tchoufack, JN; Tsapi, MT | 1 |
| Bennett, A; Chalwe, V; Chizema Kawesha, E; Conner, RO; Earle, D; Eisele, TP; Finn, TP; Hamainza, B; Kamuliwo, M; Keating, J; Kooma, E; Miller, JM; Moonga, H; Porter, T; Silumbe, K; Steketee, RW; Yukich, J | 1 |
| Duru, V; Ménard, D; Witkowski, B | 1 |
| Rogerson, SJ; Unger, HW | 1 |
| Leroy, D | 1 |
| Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
| Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
| Ashley, EA; Barnes, KI; Borrmann, S; Dahal, P; Day, NP; Edstein, MD; Guerin, PJ; Hoglund, RM; Lwin, KM; McGready, R; Mwai, L; Nosten, F; Nsanzabana, C; Ouedraogo, JB; Parikh, S; Phyo, AP; Price, RN; Quang, NN; Sambol, NC; Tarning, J; Thanh, NX; White, NJ; Workman, L; Zongo, I | 1 |
| Dong, LT; Farrar, J; Hien, TT; Nha-Ca, NT; Quang, HH; Thanh, NV; Thuy-Nhien, N; Thwaites, G; Tong, NT; Tuyen, NT; White, NJ; Wolbers, M | 1 |
| Afonso, M; Dimbu, PR; Ferreira, CM; Fortes, F; Garrett, DO; Halsey, ES; He, Y; Kelley, JS; Kiniffo, R; Macaia, AP; Mbounga, E; Patel, DS; Plucinski, MM; Quivinja, J; Ringwald, P; Samutondo, C; Talundzic, E; Udhayakumar, V | 1 |
| Day, NPJ; Dhorda, M; Dondorp, AM; Hlaing, TM; Imwong, M; Kunasol, C; Mayxay, M; Menard, D; Miotto, O; Rekol, H; Smithuis, FM; Sutawong, K; Suwannasin, K; Tripura, R; Tun, KM; van der Pluijm, RW; White, NJ | 1 |
| Buathong, N; Cantilena, L; Chann, S; Haigney, M; Ittiverakul, M; Kodchakorn, C; Kuntawunginn, W; Lanteri, C; Lon, C; Manning, J; Milner, E; Pann, ST; Prom, S; Saunders, D; So, M; Sok, S; Spring, M; Sriwichai, S; Ta-Aksorn, W; Vanachayangkul, P; Wojnarski, M; Youdaline, T | 1 |
| Cao, J; Cao, Y; Culleton, R; Gao, Q; Gu, Y; Li, J; Liu, Y; Lu, F; Menard, D; Pain, A; Ramaprasad, A; Tang, J; von Seidlein, L; Wang, W; Xu, S; Yang, H; Zhang, C; Zhang, M; Zhang, Q; Zhou, H; Zhu, G | 1 |
| Bergstrand, M; Karlsson, MO; Nosten, F; Permala, J; Tarning, J; White, NJ | 1 |
| Bukirwa, H; Dorsey, G; Kamya, MR; Lugemwa, M; Rosenthal, PJ; Rwakimari, JB; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Brittenham, GM; Kano, S; Krudsood, S; Li, G; Looareesuwan, S; Pengruksa, C; Phophak, N; Tangpukdee, N; Thanachartwet, V; Wilairatana, P | 1 |
| Brittenham, GM; Guoqiao, L; Jianping, S; Krudsood, S; Looareesuwan, S; Pothipak, N; Srivilairit, S; Tangpukdee, N; Thanchatwet, V; Wilairatana, P | 1 |
| Christophel, E; Hu, XM; Lin, SG; Liu, J; Meng, F; Wang, GZ; Wang, SQ; Zeng, LH | 1 |
| Kager, PA; Mens, PF; Omar, SA; Sawa, P; Schallig, HD; van Amsterdam, SM; Versteeg, I | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Chavchich, M; Dai, B; Edstein, MD; Phong, NC; Shanks, GD; Thanh, NX; Thien, NX; Trung, TN | 1 |
| Song, JP; Tan, B; Trung, TN; Van Phuc, D | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Ashley, EA; D'Alessandro, U; Dorsey, G; Janssens, B; Karema, C; Mayxay, M; Newton, P; Nosten, F; Singhasivanon, P; Smithuis, F; Stepniewska, K; White, NJ; Zwang, J | 1 |
| Arinaitwe, E; Dorsey, G; Greenhouse, B; Homsy, J; Kakuru, A; Kalamya, J; Kamya, MR; Rosenthal, PJ; Sandison, TG; Tappero, J; Vora, N; Wanzira, H | 1 |
| Douglas, NM; Price, RN | 1 |
| Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I | 1 |
| Arinaitwe, E; Bigira, V; Dorsey, G; Gasasira, A; Homsy, J; Kakuru, A; Kamya, MR; Katrak, S; Sandison, TG; Tappero, JW; Wanzira, H | 1 |
| Dara, P; Deng, C; Jian, H; Li, G; Ou, F; Seila, S; Socheat, D; Sokunthea, S; Song, J; Tan, B | 1 |
| Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
| Annerberg, A; Ashley, EA; Lindegardh, N; McGready, R; Nosten, F; Phaiphun, L; Singhasivanon, P; Stepniewska, K; Tarning, J; White, NJ | 1 |
| Anstey, NM; Fobia, W; Hasanuddin, A; Kenangalem, E; Lampah, DA; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Adam, I; Elhassan, AH; Elmardi, KA; Eltahir, HG; Malik, EM; Salah, MT | 1 |
| Bacchieri, A; Bhattacharya, PC; Corsi, M; Dev, V; Dubhashi, N; Duparc, S; Ghosh, SK; Keomany, S; Khanthavong, M; Krudsood, S; Kumar, A; Mayxay, M; Newton, PN; Phyo, AP; Pongvongsa, T; Pukittayakamee, S; Pukrittayakamee, S; Rao, BH; Ruangveerayuth, R; Ubben, D; Uthaisil, C; Valecha, N | 1 |
| Ariey, F; Beck, HP; Decosterd, LA; Duong, S; Genton, B; Hodel, EM; Mercier, T; Olliaro, P; Zanolari, B | 1 |
| Keola, S; Keomany, S; Khanthavong, M; Khomthilath, T; Mayxay, M; Newton, PN; Phompida, S; Pongvongsa, T; Souvannasing, P; Stepniewska, K; Ubben, D; Valecha, N; White, NJ | 1 |
| Chaponda, M; D'Alessandro, U; Hachizovu, S; Mukwamataba, D; Mulenga, M; Nambozi, M; Ubben, D; Van Geertruyden, JP | 1 |
| Dharia, NV; Eastman, RT; Fidock, DA; Winzeler, EA | 1 |
| Annerberg, A; Ashley, E; Day, NP; Khrutsawadchai, S; Lindegardh, N; Lwin, KM; Nosten, F; Singhasivanon, P; Tarning, J; White, NJ | 1 |
| Faye, B; Faye, O; Kane, D; Kassi, KF; Kiki Barro, CP; Kone, M; Kuete, T; Menan, H; N'diaye, JL; Oga, AS; Same-Ekobo, A; Tine, R; Vicky, AM; Yavo, W | 1 |
| Ama, MV; Diatta, M; Djohan, V; Evi, JB; Faye, B; Faye, O; Kassi, RR; Koné, M; Kuete, T; Ndiaye, JL; Oga, SA; Same-Ekobo, A; Tine, R; Yavo, W | 1 |
| Anstey, NM; Fobia, W; Hasanuddin, A; Kenangalem, E; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Chaisri, U; Chotivanich, K; Day, NP; Ferguson, DJ; Pongponratn, E; Sachanonta, N; Turner, GD | 1 |
| Bassat, Q; Cenci, F; Gargano, N | 1 |
| Laochan, N; Lindegardh, N; McGready, R; Mu, O; Nosten, F; Phyo, AP; Rijken, MJ; Singhasivanon, P; Tarning, J; Than, HH; White, N; Win, AK | 1 |
| Li, CF; Liu, H; Nie, RH; Wang, HY; Yang, HL; Zhang, J | 1 |
| Bentura-Marciano, A; Chan, WC; Clark, J; Golenser, J; Guiguemde, AW; Guo, J; Guy, RK; Haynes, RK; Hunt, NH; Wong, HN | 1 |
| Abdallah, A; Bashraheil, M; Borrmann, S; Fegan, G; Frühauf, H; Hanpithakpong, W; Juma, E; Lindegårdh, N; Lowe, B; Mackinnon, M; Marsh, K; Mosobo, M; Muriithi, S; Mwai, L; Nzila, A; Osier, F; Peshu, J; Peshu, N; Pfeil, J; Rippert, A; Sasi, P; Schaub, B; Tsofa, B | 1 |
| Ashley, EA; Cheah, P; Hanpithakpong, W; Lee, SJ; Lindegårdh, N; Lwin, KM; Nosten, F; Phyo, AP; Singhasivanon, P; Tarning, J; White, NJ | 1 |
| Day, NP; Hanpithakpong, W; Jongrak, N; Lindegardh, N; Nosten, F; Ouedraogo, JB; Parikh, S; Rosenthal, PJ; Rouamba, N; Somé, FA; Tarning, J; White, NJ; Zongo, I | 1 |
| Keating, GM | 1 |
| Anvikar, A; Arora, S; Gautam, A; Jha, AC; Kaur, P; Kothari, M; Krudsood, S; Mehta, S; Mohanty, R; Mohanty, S; Paliwal, JK; Rao, BS; Roy, A; Saha, N; Shahi, B; Sharma, SK; Singh, JP; Tangpukdee, N; Tyagi, PK; Valecha, N | 1 |
| Adam, I; Lindegardh, N; Mahgoub, H; McGready, R; Nosten, F; Tarning, J | 1 |
| Bacchieri, A; Bhattacharyya, PC; Corsi, M; Dev, V; Dubashi, N; Gargano, N; Ghosh, SK; Kumar, A; Rao, BH; Srivastava, B; Tommasini, S; Ubben, D; Valecha, N | 1 |
| Liu, H; Wang, J; Zhang, CL; Zhou, HN | 1 |
| Charman, SA; Gamo-Benito, J; Humberstone, A; Jamsen, KM; McCaw, J; Moehrle, J; Price, RN; Simpson, JA; Smith, K; Zaloumis, S | 1 |
| Boni, MF; Dolecek, C; Dong, le T; Farrar, J; Hien, TT; Long, le T; Merson, L; Nha-Ca, NT; Phu, NH; Ringwald, P; Stepniewska, K; Thai, CQ; Thai, le H; Thanh, NV; Thuan, PD; Thuy-Nhien, NT; Toi, PV; White, NJ; Wolbers, M | 1 |
| Dahlan, MS; Hawley, WA; Kosasih, A; Kusriastuti, R; Lobo, NF; Suprijanto, S; Sutanto, I; Syafruddin, D; Ter Kuile, FO | 1 |
| Adam, I; Ashton, M; Day, NP; Hanpithakpong, W; Hoglund, RM; Lindegardh, N; Nosten, F; Tarning, J; White, NJ | 1 |
| Abdur, R; Barrette, A; Bouth, DM; Duong, S; Leang, R; Menard, D; Ringwald, P | 1 |
| Achan, J; D'Alessandro, U; Talisuna, AO; Tibenderana, J; Yeka, A | 1 |
| Arinaitwe, E; Bigira, V; Dorsey, G; Homsy, J; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, M; Osilo, E; Tappero, JW; Wanzira, H | 1 |
| Davis, TM; Denis, MB; Fandeur, T; Hewitt, S; Incardona, S; Lim, C; Nimol, K; Poravuth, Y; Socheat, D | 1 |
| Chalermrut, K; Krudsood, S; Looareesuwan, S; Pengruksa, C; Silachamroon, U; Srivilairit, S; Treeprasertsuk, S; Wilairatana, P | 1 |
| Davis, TM; Hung, TY; Ilett, KF | 1 |
| Feng, XP; Liu, DQ | 1 |
| Davis, TM; Denis, MB; Hung, TY; Ilett, KF; Karunajeewa, H; Lim, C; Socheat, D | 1 |
| Dolecek, C; Dong, TH; Farrar, J; Le, HT; Nguyen, TD; Nguyen, TT; Pham, PM; Stepniewska, K; Tran, TH; Tran, TT; White, NJ | 1 |
| Davis, TM; Denis, MB; Hewitt, S; Hung, TY; Ilett, KF; Karunajeewa, H; Lim, C; Socheat, D | 1 |
| Binh, TQ; de Vries, PJ; Giao, PT; Hung, le Q; Kager, PA; Nam, NV | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Krudsood, S; Leowattana, W; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Srivilairit, S; White, NJ; Wilairatana, P | 1 |
| Diallo, TO; Doui-Doumgba, K; Flori, P; Garraud, O; Gbagba, FE; Nambei, WS; Ndadjimbaye, V; Ndémanga, J; Perraut, R | 1 |
| Ashley, EA; Barends, M; Hutagalung, R; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Proux, S; Slight, T; Thwai, KL; White, NJ | 1 |
| Kokwaro, G | 1 |
| Chalermrut, K; Kano, S; Krudsood, S; Looareesuwan, S; Pengruksa, C; Phongtananant, S; Silachamroon, U; Srivilairit, S; Tangpukdee, N; Thanachartwet, W; Wilairatana, P | 1 |
| D'Alessandro, U; Fanello, CI; Karema, C; Ngamije, D; van Doren, W; van Geertruyden, JP; van Overmeir, C | 1 |
| Duffy, PE; Mutabingwa, TK | 1 |
| Ashley, E; Aye, KZ; Barends, M; Htet, L; Kyaw, MK; Lindegardh, N; Lwin, S; Phe, O; Singtoroj, T; Smithuis, F; Stepniewska, K; White, NJ | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
| Anstey, NM; Ebsworth, EP; Kenangalem, E; Laihad, F; Maristela, R; Price, RN; Ratcliff, A; Siswantoro, H; Tjitra, E; Wuwung, RM | 1 |
| Anstey, NM; Ebsworth, EP; Hasugian, AR; Kenangalem, E; Laihad, F; Maristela, R; Penttinen, PM; Price, RN; Purba, HL; Tjitra, E; Wuwung, RM | 1 |
| Ashley, EA; Day, NP; Myint, HY; Nosten, F; White, NJ | 1 |
| Bernasconi, A; Casapia, M; D'Alessandro, U; Delgado, C; Erhart, A; Fanello, C; Gamboa, D; Grande, T; Llanos-Cuentas, A; Torres, K | 1 |
| Dokomajilar, C; Dorsey, G; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, Y; Zongo, I | 1 |
| Barends, M; Boel, ME; McGready, R; Nosten, F; Pimanpanarak, M; Proux, S; Rijken, MJ; Singhasivanon, P | 1 |
| Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; McGready, R; Poespoprodjo, JR; Price, RN; Seal, A; Sugiarto, P; Tjitra, E; Warikar, N | 1 |
| Guo, XB | 1 |
| Fan, B; Huang, Z; Ma, X; Wen, Y; Yang, J; Yang, Z; Zhao, W | 1 |
24 review(s) available for piperaquine and Malaria, Falciparum
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Comparative effect of dihydroartemisinin-piperaquine and artemether-lumefantrine on gametocyte clearance and haemoglobin recovery in children with uncomplicated Plasmodium falciparum malaria in Africa: a systematic review and meta-analysis of randomized c
Topics: Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; Hemoglobins; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic | 2021 |
Safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
Topics: Adolescent; Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic | 2022 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review.
Topics: Antimalarials; Artemisinins; Biomarkers; Drug Resistance; Humans; Malaria, Falciparum; Mass Drug Administration; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana.
Topics: Antimalarials; Child; Drug Combinations; Ghana; Humans; Malaria; Malaria, Falciparum; Parasitemia; Treatment Outcome | 2022 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bias; Child; Child, Preschool; Confidence Intervals; Drug Combinations; Humans; Infant; Malaria, Falciparum; Quinolines; Randomized Controlled Trials as Topic; Suspensions; Tablets; Treatment Failure; Vomiting | 2020 |
Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Quinolines; Randomized Controlled Trials as Topic; Uganda | 2021 |
Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
Topics: Adolescent; Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Polymerase Chain Reaction; Quality Control; Quinolines; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Time Factors | 2021 |
Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Pregnancy; Pregnancy Trimester, First; Pyrimethamine; Quinine; Quinolines; Rabbits; Rats; Sulfadoxine; Teratogens | 2017 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data.
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Quinolines; Risk Factors | 2013 |
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic | 2014 |
Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Naphthoquinones; Quinolines; Randomized Controlled Trials as Topic | 2015 |
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.
Topics: Africa; Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prospective Studies; Quinolines | 2015 |
Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.
Topics: Animals; Artemisinins; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2016 |
Prevention and control of malaria in pregnancy - new threats, new opportunities?
Topics: Adult; Animals; Antimalarials; Artemisinins; Culicidae; Drug Combinations; Drug Resistance; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Malaria, Vivax; Pregnancy; Pregnancy Complications, Parasitic; Primary Prevention; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.
Topics: Antimalarials; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2017 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Malaria, Vivax; Quinolines; Treatment Outcome | 2011 |
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Efficacy and safety of dihydroartemisinin-piperaquine.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Quinolines; Sesquiterpenes; Treatment Outcome | 2007 |
137 trial(s) available for piperaquine and Malaria, Falciparum
| Article | Year |
|---|---|
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2008 |
Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Area Under Curve; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Quinolines; Thailand; Treatment Outcome | 2008 |
Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.
Topics: Adolescent; Antimalarials; Artemisinins; Humans; Malaria, Falciparum; Male; Middle Aged; Quinolines; Vietnam; Young Adult | 2009 |
In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.
Topics: Antimalarials; Child; Child, Preschool; Cohort Studies; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Treatment Outcome; Uganda | 2010 |
Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Congo; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Piperazines; Plasmodium falciparum; Quinolines | 2021 |
Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial.
Topics: Aftercare; Anemia; Antimalarials; Artemisinins; Child, Preschool; Delivery of Health Care; Drug Combinations; Female; Health Facilities; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Patient Discharge; Plasmodium falciparum; Quinolines; Social Welfare | 2021 |
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children.
Topics: Algorithms; Antimalarials; Artemisinins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Models, Biological; Outcome Assessment, Health Care; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Uganda | 2021 |
Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
Topics: Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Piperazines; Placenta; Pregnancy; Pregnant Women; Quinolines; Uganda | 2022 |
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.
Topics: Aminoquinolines; Animals; Artemisinins; Humans; Malaria; Malaria, Falciparum; Mali; Piperazines; Plasmodium falciparum; Quinolines; Single-Blind Method | 2022 |
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemisinins; Chemoprevention; Child; Child, Preschool; Drug Combinations; Female; Humans; Hydroxyurea; Infant; Kenya; Malaria; Malaria, Falciparum; Male; Proguanil; Pyrimethamine; Sulfadoxine | 2022 |
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2022 |
Effectiveness and safety of intermittent preventive treatment with dihydroartemisinin-piperaquine or artesunate-amodiaquine for reducing malaria and related morbidities in schoolchildren in Tanzania: a randomised controlled trial.
Topics: Amodiaquine; Antimalarials; Artesunate; Child; COVID-19; Drug Combinations; Hemoglobins; Humans; Incidence; Malaria; Malaria, Falciparum; Quinolines; Tanzania | 2023 |
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women.
Topics: Adult; Antimalarials; Asymptomatic Diseases; Azithromycin; Chemoprevention; Drug Combinations; Erythrocytes; Female; Gestational Age; Humans; Live Birth; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinolines; Random Allocation; Severity of Illness Index; Stillbirth; Sulfadoxine | 2019 |
Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial.
Topics: Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Antimalarials; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Female; Humans; Malaria, Falciparum; Malawi; Male; Middle Aged; Mozambique; Nevirapine; Plasmodium falciparum; Quinolines; Young Adult | 2019 |
Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
Topics: Administration, Intravenous; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Osmolar Concentration; Plasmodium falciparum; Quinine; Quinolines; Recurrence; Treatment Outcome; Uganda | 2019 |
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mass Drug Administration; Myanmar; Prevalence; Primaquine; Quinolines; Recurrence; Treatment Outcome; Vietnam; Young Adult | 2020 |
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
Topics: Adolescent; Adult; Amodiaquine; Anthraquinones; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult | 2020 |
Impact of Intermittent Mass Testing and Treatment on Incidence of Malaria Infection in a High Transmission Area of Western Kenya.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Female; Humans; Incidence; Kenya; Malaria, Falciparum; Male; Mass Screening; Quinolines | 2020 |
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Microfilament Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines; Senegal; Sequence Analysis, DNA; Treatment Failure | 2020 |
Assessment of the Acceptability of Testing and Treatment during a Mass Drug Administration Trial for Malaria in Zambia Using Mixed Methods.
Topics: Adult; Artemisinins; Attitude to Health; Disease Eradication; Drug Therapy, Combination; Female; Focus Groups; Humans; Malaria, Falciparum; Male; Mass Drug Administration; Medication Adherence; Middle Aged; Patient Acceptance of Health Care; Quinolines; Zambia | 2020 |
A Longitudinal Cohort to Monitor Malaria Infection Incidence during Mass Drug Administration in Southern Province, Zambia.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Disease Eradication; Drug Therapy, Combination; Family Characteristics; Female; Humans; Incidence; Longitudinal Studies; Malaria, Falciparum; Male; Mass Drug Administration; Quinolines; Young Adult; Zambia | 2020 |
Implications of the MDA Trial in Southern Province, Zambia, for Malaria Control and Elimination.
Topics: Antimalarials; Artemisinins; Disease Eradication; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mass Drug Administration; Plasmodium falciparum; Prevalence; Program Evaluation; Quinolines; Zambia | 2020 |
Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial.
Topics: Antimalarials; Artemisinins; Cost-Benefit Analysis; Disease Eradication; Drug Costs; Drug Therapy, Combination; Health Care Costs; Humans; Malaria, Falciparum; Mass Drug Administration; Plasmodium falciparum; Quality-Adjusted Life Years; Quinolines; Zambia | 2020 |
Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin-Piperaquine Implemented in Southern Province, Zambia.
Topics: Antimalarials; Artemisinins; Disease Eradication; Drug Therapy, Combination; Humans; Incidence; Malaria, Falciparum; Mass Drug Administration; Program Evaluation; Quinolines; Zambia | 2020 |
Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin-Piperaquine in Southern Province, Zambia.
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Family Characteristics; Humans; Malaria, Falciparum; Mass Drug Administration; Program Evaluation; Quinolines; Zambia | 2020 |
Moving from Malaria Burden Reduction toward Elimination: An Evaluation of Mass Drug Administration in Southern Province, Zambia.
Topics: Antimalarials; Artemisinins; Disease Eradication; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mass Drug Administration; Program Evaluation; Quinolines; Zambia | 2020 |
Infant sex modifies associations between placental malaria and risk of malaria in infancy.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria, Falciparum; Male; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2020 |
Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Asymptomatic Infections; Child; Child, Preschool; Cluster Analysis; Drug Combinations; Female; Gambia; Humans; Incidence; Infant; Malaria, Falciparum; Male; Middle Aged; Prevalence; Quinolines; Self Administration; Young Adult | 2021 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Topics: Administration, Oral; Antimalarials; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Heterocyclic Compounds, 1-Ring; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds; Treatment Outcome | 2021 |
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Cluster Analysis; Disease Eradication; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mass Drug Administration; Myanmar; Primaquine; Quinolines; Young Adult | 2021 |
Imatinib augments standard malaria combination therapy without added toxicity.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Fever; Humans; Imatinib Mesylate; Malaria, Falciparum; Middle Aged; Quinolines; Treatment Outcome; Vietnam; Young Adult | 2021 |
Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Quinolines; Sudan; Sulfadoxine; Time Factors; Treatment Outcome; Young Adult | 2017 |
Changing Antimalarial Drug Sensitivities in Uganda.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Child; Child, Preschool; Chloroquine; Drug Resistance; Ethanolamines; Female; Fluorenes; Gene Expression; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinolines; Uganda; Young Adult | 2017 |
A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Asian People; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinolines; Treatment Outcome; Young Adult | 2017 |
Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Rando
Topics: Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heterocyclic Compounds, 1-Ring; Humans; India; Infant; Malaria, Falciparum; Male; Peroxides; Quinolines; Spiro Compounds; Survival Analysis; Tablets | 2017 |
Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infa
Topics: Africa; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Quinolines; Treatment Outcome | 2018 |
Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and inc
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Clinical Protocols; Community Health Services; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Quinolines; Research Design; Risk Factors; Time Factors; Treatment Outcome; Young Adult; Zambia | 2017 |
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Artemisinins; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Proof of Concept Study; Quinolines; Treatment Outcome; Young Adult | 2018 |
Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Male; Niger; Parasite Load; Quinolines | 2018 |
A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.
Topics: Adamantane; Adolescent; Adult; Animals; Antimalarials; Culicidae; Erythrocytes; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Models, Biological; Peroxides; Plasmodium falciparum; Primaquine; Quinolines | 2018 |
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
Topics: Adolescent; Adult; Amodiaquine; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Malaria, Falciparum; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2018 |
A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Multiple; Female; Humans; Incidence; Malaria, Falciparum; Male; Mass Drug Administration; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Prevalence; Quinolines; Young Adult | 2018 |
Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine.
Topics: Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Newborn; Malaria, Falciparum; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines | 2018 |
Comparison of Two Genotyping Methods for Distinguishing Recrudescence from Reinfection in Antimalarial Drug Efficacy/Effectiveness Trials.
Topics: Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Cluster Analysis; Drug Combinations; Female; Gene Expression; Genotype; Genotyping Techniques; Humans; Malaria, Falciparum; Malawi; Male; Merozoite Surface Protein 1; Merozoites; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines; Recurrence; Treatment Outcome | 2018 |
High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Tanzania | 2018 |
Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Time Factors; Treatment Outcome; Uganda; Young Adult | 2018 |
A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Mali; Middle Aged; Plasmodium falciparum; Quinolines; Young Adult | 2018 |
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Quinolines; Young Adult | 2018 |
Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Disease Eradication; Drug Administration Schedule; Drug Combinations; Female; Humans; Insecticides; Malaria, Falciparum; Male; Mass Screening; Middle Aged; Military Medicine; Military Personnel; Mosquito Control; Pilot Projects; Plasmodium falciparum; Predictive Value of Tests; Primaquine; Protective Clothing; Quinolines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Young Adult | 2018 |
The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Asymptomatic Infections; Child; Drug Combinations; Female; Humans; Incidence; Laos; Malaria, Falciparum; Male; Mass Drug Administration; Middle Aged; Plasmodium falciparum; Prevalence; Quinolines; Young Adult | 2018 |
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Comparative Effectiveness Research; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Quinolines; Recurrence; Single-Blind Method; Uganda | 2019 |
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children.
Topics: Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Quinolines; Seasons | 2019 |
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
Topics: Adult; Antimalarials; Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Uganda; Young Adult | 2019 |
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker.
Topics: Adamantane; Adolescent; Adult; Africa; Aged; Antimalarials; Aspartic Acid Endopeptidases; Biomarkers; Child; Child, Preschool; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Peroxides; Plasmodium falciparum; Protozoan Proteins; Quinolines; Vietnam; Young Adult | 2019 |
Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria, Falciparum; Malawi; Mass Screening; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2019 |
High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinolines; Somalia; Young Adult | 2019 |
Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasitemia; Quinolines; Risk Assessment; Uganda; Withholding Treatment | 2019 |
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Drug Resistance, Multiple; Drug Therapy, Combination; Female; High-Throughput Nucleotide Sequencing; Humans; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Quinolines; Thailand; Treatment Failure; Vietnam; Young Adult | 2019 |
Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-la
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Parturition; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Quinolines; Young Adult | 2019 |
Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.
Topics: Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Culicidae; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Secondary Prevention; Time Factors; Treatment Outcome | 2013 |
A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Quinolines; Treatment Outcome | 2013 |
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chi-Square Distribution; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Recurrence | 2013 |
Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Population Surveillance; Quinolines; Senegal; Young Adult | 2013 |
Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Fasting; Humans; Malaria, Falciparum; Middle Aged; Monte Carlo Method; Quinolines; Young Adult | 2014 |
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Kinetics; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Quinolines; Risk Factors; Uganda | 2014 |
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Tablets | 2014 |
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Child; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Parasitemia; Prevalence; Quinolines; Risk Factors; Uganda | 2014 |
Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
Topics: Adult; Antimalarials; Artemisinins; Cambodia; Drug Administration Schedule; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Military Personnel; Models, Biological; Quinolines; Recurrence | 2014 |
Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; HIV Infections; Hospitalization; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Quinolines; Recurrence; Time Factors; Treatment Outcome; Uganda | 2014 |
[Therapeutic efficacy and safety of compound dihydroartemisinin/piperaquine for uncomplicated Plasmodium falciparum infection in Laiza City of Myanmar bordering on China].
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2011 |
Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Erythrocyte Count; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome | 2014 |
Dihydroartemisinin-piperaquine failure in Cambodia.
Topics: Adult; Antimalarials; Artemisinins; Cambodia; Drug Combinations; Humans; Malaria, Falciparum; Quinolines; Recurrence; Treatment Failure | 2014 |
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
Topics: Antimalarials; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Treatment Failure | 2014 |
Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Erythrocytes; Female; Genotyping Techniques; Humans; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Male; Microfilament Proteins; Middle Aged; Molecular Typing; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinolines; Time Factors; Vietnam | 2014 |
Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cameroon; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Treatment Outcome | 2015 |
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
Topics: Adolescent; Adult; Antigens, Bacterial; Antigens, Surface; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Treatment Failure; Young Adult | 2015 |
Clinical Efficacy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria at the China-Myanmar Border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; China; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Myanmar; Quinolines; Treatment Outcome; Young Adult | 2015 |
Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study.
Topics: Antimalarials; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Female; Heterocyclic Compounds, 1-Ring; Humans; India; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Male; Peroxides; Plasmodium falciparum; Quinolines; Rwanda; Spiro Compounds; Tablets | 2015 |
Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood.
Topics: Artemisinins; Child, Preschool; Drug Combinations; GPI-Linked Proteins; Humans; Immune Tolerance; Infant; Longitudinal Studies; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinolines; Receptors, Antigen, T-Cell, gamma-delta; Receptors, IgG; Sulfadoxine; T-Lymphocyte Subsets; Up-Regulation | 2016 |
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mali; Primaquine; Quinolines; Single-Blind Method | 2016 |
A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Artemether; Artemisinins; Asia; Child; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; India; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds; Young Adult | 2016 |
Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; CD4-Positive T-Lymphocytes; Chemoprevention; Child, Preschool; Female; Humans; Infant; Interleukin-10; Malaria, Falciparum; Male; Quinolines; Uganda; Young Adult | 2016 |
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children.
Topics: Age Factors; Anemia; Antimalarials; Artemisinins; Child, Preschool; Cognition; Cognition Disorders; Coinfection; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.
Topics: Adolescent; Amodiaquine; Anemia; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Prognosis; Quinolines; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Female; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pre-Exposure Prophylaxis; Protozoan Proteins; Quinolines; Uganda | 2016 |
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.
Topics: Antimalarials; Artemether; Artemisinins; Child; Ethanolamines; Fluorenes; Guinea-Bissau; Humans; Lumefantrine; Malaria, Falciparum; Quinolines; Treatment Outcome | 2016 |
The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.
Topics: Adolescent; Antimalarials; Artemisinins; Asymptomatic Diseases; Carrier State; Child; Drug Therapy, Combination; Female; Gambia; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Quinolines; Treatment Outcome | 2016 |
Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.
Topics: Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Drug Therapy; Family Characteristics; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Prevalence; Quinolines; Treatment Outcome; Zambia | 2016 |
Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.
Topics: Antimalarials; Arrhythmias, Cardiac; Artemisinins; Cambodia; Cardiotoxicity; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Myocardial Contraction; Plasmodium falciparum; Quinolines | 2017 |
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Infant; Lumefantrine; Malaria, Falciparum; Quinolines; Uganda | 2008 |
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Prospective Studies; Quinolines; Thailand; Treatment Outcome | 2008 |
Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Quinolines; Thailand | 2007 |
[Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2008 |
A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Microscopy; Parasitemia; Plasmodium falciparum; Quinolines; Self-Sustained Sequence Replication; Treatment Outcome | 2008 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pilot Projects; Quinolines; Treatment Outcome; Vietnam; Young Adult | 2009 |
A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Integrative Medicine; Malaria, Falciparum; Male; Quinolines; Treatment Outcome; Young Adult | 2009 |
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Quinolines; Treatment Outcome; Uganda | 2009 |
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors | 2009 |
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Quinolines; Risk Factors; Treatment Outcome; Uganda | 2009 |
Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan.
Topics: Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Sudan; Treatment Outcome | 2010 |
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Young Adult | 2010 |
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Quinolines; Young Adult | 2010 |
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Treatment Outcome; Zambia | 2011 |
A small amount of fat does not affect piperaquine exposure in patients with malaria.
Topics: Adolescent; Adult; Aged; Artemisinins; Chromatography, Liquid; Dietary Fats; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Quinolines; Tandem Mass Spectrometry; Young Adult | 2011 |
Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Cameroon; Child; Child, Preschool; Cote d'Ivoire; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Senegal; Treatment Outcome; Trimethoprim; Young Adult | 2011 |
Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cameroon; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Quinolines; Senegal; Treatment Outcome; Young Adult | 2011 |
[Efficacy of compound dihydroartemisinin/piperaquine in treatment of uncomplicated falciparum malaria in Myanmar].
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Myanmar; Quinolines; Tablets; Treatment Outcome; Young Adult | 2011 |
Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines; Survival Rate | 2011 |
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Chemoprevention; Dietary Fats; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Hematocrit; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Placebos; Plasmodium falciparum; Plasmodium vivax; Quinolines; Risk; Thailand | 2012 |
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
Topics: Artemisinins; Body Weight; Burkina Faso; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Quinolines | 2012 |
Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial.
Topics: Adolescent; Adult; Antimalarials; Female; Heterocyclic Compounds, 1-Ring; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Peroxides; Quinolines; Spiro Compounds; Statistics, Nonparametric | 2012 |
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2012 |
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines; Treatment Outcome; Vietnam; Young Adult | 2012 |
The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase; Humans; Indonesia; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome; Young Adult | 2013 |
Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Quinine; Quinolines; Safety; Treatment Outcome; Uganda | 2013 |
The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Multivariate Analysis; Parasitemia; Plasmodium falciparum; Post-Exposure Prophylaxis; Prevalence; Proportional Hazards Models; Quinolines; Risk Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Trophozoites; Uganda | 2013 |
Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Sesquiterpenes; Treatment Outcome | 2002 |
An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Sesquiterpenes; Thailand; Trimethoprim | 2002 |
Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Blood Glucose; Cambodia; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Electrocardiography; Heart Rate; Hematocrit; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Middle Aged; Quinolines; Sesquiterpenes | 2004 |
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Pilot Projects; Plasmodium falciparum; Quinolines; Sesquiterpenes; Treatment Outcome; Trimethoprim; Vietnam | 2004 |
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Primaquine; Proguanil; Quinolines; Sesquiterpenes; Treatment Outcome; Trimethoprim; Vietnam | 2004 |
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes; Thailand | 2004 |
Efficacy comparison between anti-malarial drugs in Africans presenting with mild malaria in the Central Republic of Africa: a preliminary study.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Central African Republic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Parasitic Sensitivity Tests; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Trimethoprim | 2005 |
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2005 |
An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Quinolines; Sesquiterpenes; Thailand; Treatment Outcome | 2005 |
Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
Topics: Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Leukocyte Count; Malaria, Falciparum; Male; Quinolines; Rwanda; Sesquiterpenes; Treatment Outcome | 2006 |
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Diarrhea; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Indonesia; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Prospective Studies; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome; Urticaria; Vomiting | 2007 |
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Tolerance; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Quinolines; Sesquiterpenes; Treatment Outcome | 2007 |
A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Quinolines; Sesquiterpenes | 2007 |
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 2007 |
[Randomised comparison on the treatment of falciparum malaria with dihydroartemisinin and piperaquine].
Topics: Adult; Antimalarials; Artemisinins; Drug Evaluation; Female; Humans; Malaria, Falciparum; Male; Quinolines; Sesquiterpenes | 1993 |
161 other study(ies) available for piperaquine and Malaria, Falciparum
| Article | Year |
|---|---|
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
Topics: Animals; Antimalarials; Artemisinins; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinolines | 2009 |
Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity.
Topics: Animals; Antimalarials; Artemisinins; Culicidae; Drug Therapy, Combination; Humans; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Primaquine; Quinolines | 2022 |
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Biomarkers; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Uganda | 2021 |
Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Chloroquine; Computer Simulation; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Membrane Transport Proteins; Piperazines; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2022 |
Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China-Myanmar, Thailand-Myanmar, and Thailand-Cambodia borders.
Topics: Antimalarials; Artemisinins; Biomarkers; Cambodia; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Myanmar; Piperazines; Plasmodium falciparum; Protozoan Proteins; Quinolines; Thailand | 2022 |
A single point mutation in the Plasmodium falciparum 3'-5' exonuclease does not alter piperaquine susceptibility.
Topics: Animals; Antimalarials; Chloroquine; DNA Copy Number Variations; Drug Resistance; Exonucleases; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Parasites; Phosphodiesterase I; Piperazines; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinolines | 2022 |
Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Piperazines; Primary Health Care; Quinolines; Treatment Outcome | 2022 |
Artesunate and dihydroartemisinin-piperaquine treatment failure in a severe Plasmodium falciparum malaria case imported from Republic of Côte d'Ivoire.
Topics: Aged; Antimalarials; Artemisinins; Artesunate; Cote d'Ivoire; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Male; Piperazines; Plasmodium falciparum; Quinolines; Treatment Failure | 2022 |
Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin-Piperaquine.
Topics: Adult; Antimalarials; Artemisinins; Female; Healthy Volunteers; Humans; Long QT Syndrome; Longitudinal Studies; Malaria, Falciparum; Male; Papua New Guinea; Piperazines; Quinolines | 2022 |
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection | 2022 |
Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Resistance; Gabon; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2022 |
Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Heme; Hemoglobins; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Parasites; Plasmodium falciparum; Protozoan Proteins | 2022 |
Therapeutic efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium vivax malaria in Seacha area, Arbaminch Zuria District, South West Ethiopia.
Topics: Antimalarials; Artemisinins; Ethiopia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax | 2022 |
Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Quinolines | 2023 |
Comparative efficacy of sulphadoxine-pyrimethamine and dihydroartemisinin-piperaquine against malaria infection during late-stage pregnancy in mice.
Topics: Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Malaria; Malaria, Falciparum; Mice; Plasmodium berghei; Pregnancy; Pyrimethamine | 2023 |
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection | 2023 |
Effectiveness of dihydroartemisinin-piperaquine after 10 years as treatment for vivax malaria in Indonesia.
Topics: Adult; Antimalarials; Child; Humans; Indonesia; Malaria; Malaria, Falciparum; Malaria, Vivax; Prospective Studies | 2023 |
PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
Topics: Antimalarials; Chloroquine; Drug Resistance; Humans; Kinetics; Malaria, Falciparum; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2023 |
Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.
Topics: Antimalarials; DNA Copy Number Variations; Drug Resistance; Genetic Markers; Humans; Indonesia; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2023 |
Dihydroartemisinin-piperaquine efficacy in Plasmodium falciparum treatment and prevalence of drug-resistant molecular markers along China-Myanmar border in 2014-2023.
Topics: Antimalarials; China; Humans; Malaria, Falciparum; Myanmar; Plasmodium falciparum; Prevalence | 2023 |
Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
Topics: Africa; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2019 |
Suboptimal dosing triggers artemisinin partner drug resistance.
Topics: Artemisinins; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Prospective Studies; Quinolines; Thailand; Treatment Failure; Vietnam | 2019 |
Plasmodium falciparum resistance to piperaquine driven by PfCRT.
Topics: Asia, Southeastern; Genomics; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2019 |
Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Quinolines | 2019 |
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.
Topics: Antimalarials; Atovaquone; Drug Design; Electron Transport Chain Complex Proteins; Humans; Life Cycle Stages; Malaria, Falciparum; Metabolome; Metabolomics; Mitochondria; Plasmodium falciparum; Quinolines | 2020 |
Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Retain High Efficacy for Treatment of Uncomplicated
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Myanmar; Plasmodium falciparum; Quinolines; Young Adult | 2020 |
Artenimol-piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort.
Topics: Adolescent; Artemisinins; Child; Child, Preschool; Communicable Diseases, Imported; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Infant; Malaria, Falciparum; Male; Prospective Studies; Quinolines; Treatment Outcome | 2019 |
Multigenic architecture of piperaquine resistance trait in Plasmodium falciparum.
Topics: Asia, Southeastern; Genomics; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2020 |
Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Topics: Antimalarials; Artemisinins; Atovaquone; Codon; Congo; Cytochromes b; Drug Combinations; Drug Resistance; Female; France; Humans; Malaria, Falciparum; Middle Aged; Mutation; Phenanthrenes; Plasmodium falciparum; Proguanil; Quinolines; Tetrahydrofolate Dehydrogenase; Travel | 2020 |
Turning the tide: targeting PfCRT to combat drug-resistant P. falciparum?
Topics: Antimalarials; Chloroquine; Drug Resistance; Evolution, Molecular; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutant Proteins; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2020 |
Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria.
Topics: Africa; Antimalarials; Child; Humans; Malaria; Malaria, Falciparum; Quinolines | 2020 |
Liver Enzyme Elevations in
Topics: Acrylamides; Adamantane; Adult; Alanine Transaminase; Aminopyridines; Aminoquinolines; Antimalarials; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Erythrocyte Transfusion; Erythrocytes; Female; Ferrous Compounds; Healthy Volunteers; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Isoquinolines; Malaria, Falciparum; Male; Metallocenes; Parasitemia; Peroxides; Piperazines; Plasmodium falciparum; Primaquine; Pyrimidines; Quinolines; Spiro Compounds; Sulfones; Triazoles; Young Adult | 2020 |
The Impact of Control Interventions on Malaria Burden in Young Children in a Historically High-Transmission District of Uganda: A Pooled Analysis of Cohort Studies from 2007 to 2018.
Topics: Antimalarials; Artemisinins; Child, Preschool; Cohort Studies; Communicable Disease Control; Directly Observed Therapy; Female; Housing; Humans; Infant; Insecticides; Malaria, Falciparum; Male; Mosquito Control; Organothiophosphorus Compounds; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2020 |
Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Vietnam | 2020 |
Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2020 |
Altered Drug Transport by
Topics: Antimalarials; Biological Transport; Cell Culture Techniques; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Models, Molecular; Mutation; Plasmodium falciparum; Protein Isoforms; Protozoan Proteins; Quinolines; Structure-Activity Relationship | 2020 |
Recent Travel History and
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Family Characteristics; Female; Humans; Malaria, Falciparum; Male; Mass Drug Administration; Plasmodium falciparum; Prevalence; Quinolines; Risk Factors; Travel; Zambia | 2020 |
Mass testing and treatment for malaria followed by weekly fever screening, testing and treatment in Northern Senegal: feasibility, cost and impact.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Diagnostic Tests, Routine; Feasibility Studies; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Mass Screening; Middle Aged; Plasmodium falciparum; Quinolines; Senegal; Young Adult | 2020 |
Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy.
Topics: Antimalarials; Drug Combinations; Female; Humans; Indonesia; Kenya; Malaria; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Quinolines | 2021 |
Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017-2018.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child, Preschool; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines | 2021 |
Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria.
Topics: Antimalarials; Australia; Humans; Malaria; Malaria, Falciparum; New Zealand; Plasmodium falciparum; Quinolines; Volunteers | 2021 |
Distribution and Temporal Dynamics of Plasmodium falciparum Chloroquine Resistance Transporter Mutations Associated With Piperaquine Resistance in Northern Cambodia.
Topics: Animals; Antimalarials; Biomarkers; Cambodia; Drug Resistance; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Mutation; Piperazines; Plasmodium falciparum; Prevalence; Protozoan Proteins; Quinolines; Real-Time Polymerase Chain Reaction | 2021 |
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines | 2021 |
Unintentional artenimol/piperaquine overdose in two children occurring without evidence of subsequent cardiotoxicity.
Topics: Antimalarials; Artemisinins; Cardiotoxicity; Child; Child, Preschool; Drug Overdose; Drug Therapy, Combination; Humans; Malaria, Falciparum; Paris; Quinolines | 2021 |
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.
Topics: Adolescent; Adult; Aged; Artemisinins; Belgium; Child; Child, Preschool; Communicable Diseases, Imported; Drug Combinations; Female; France; Germany; Humans; Italy; Longitudinal Studies; Malaria, Falciparum; Male; Middle Aged; Quinolines; Registries; Spain; United Kingdom; Young Adult | 2021 |
Arterolane-based combinations for the treatment of uncomplicated falciparum malaria in Kenyan children.
Topics: Antimalarials; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Heterocyclic Compounds, 1-Ring; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds | 2021 |
Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; DNA Copy Number Variations; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Genetic Association Studies; Genotype; Haplotypes; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Quinolines; Thailand; Young Adult | 2021 |
Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Indonesia; Malaria, Falciparum; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines | 2021 |
Isolation of Mutants With Reduced Susceptibility to Piperaquine From a Mutator of the Rodent Malaria Parasite
Topics: Animals; Antimalarials; Malaria; Malaria, Falciparum; Mice; Parasites; Plasmodium berghei; Plasmodium falciparum; Protozoan Proteins; Quinolines; Rodentia | 2021 |
Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaoundé, Cameroon.
Topics: Antimalarials; Artemisinins; Cameroon; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2021 |
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines; Vietnam | 2017 |
Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Ghana; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines | 2017 |
A Variant PfCRT Isoform Can Contribute to
Topics: Antimalarials; Artemisinins; Cambodia; Drug Resistance; Gene Editing; Humans; Lethal Dose 50; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protein Isoforms; Protozoan Proteins; Quinolines | 2017 |
Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.
Topics: Adolescent; Adult; Animals; Antimalarials; Australia; Biomarkers; Carrier Proteins; Female; Humans; Life Cycle Stages; Linear Models; Malaria, Falciparum; Male; Membrane Proteins; Middle Aged; Parasite Load; Plasmodium falciparum; Protozoan Proteins; Quinolines; Young Adult | 2017 |
[Elimination in South-East Asia? The role of antimalarial drugs].
Topics: Antimalarials; Artemether; Artemisinins; Asia, Southeastern; Disease Eradication; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Quinolines | 2016 |
Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
Topics: Adult; Antipruritics; Artemisinins; Cambodia; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Phylogeny; Plasmodium falciparum; Protozoan Proteins; Quinolines; Treatment Failure | 2017 |
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda.
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Drug-resistant malaria advances in Mekong.
Topics: Antimalarials; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Vietnam; World Health Organization | 2017 |
The prevalence, incidence and prevention of Plasmodium falciparum infections in forest rangers in Bu Gia Map National Park, Binh Phuoc province, Vietnam: a pilot study.
Topics: Adult; Antibiotic Prophylaxis; Antimalarials; Artemisinins; Drug Therapy, Combination; Feasibility Studies; Humans; Incidence; Malaria, Falciparum; Male; Occupational Diseases; Parks, Recreational; Pilot Projects; Plasmodium falciparum; Prevalence; Primaquine; Quinolines; Vietnam | 2017 |
Researchers and WHO clash over global threat of drug resistant malaria.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance, Microbial; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Research; Tropical Medicine; World Health Organization | 2017 |
Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.
Topics: Amodiaquine; Anemia; Antimalarials; Area Under Curve; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Hematocrit; Humans; Infant; Kaplan-Meier Estimate; Logistic Models; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Odds Ratio; Quinolines; ROC Curve; Treatment Outcome | 2017 |
Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz.
Topics: Adult; Alkynes; Anti-HIV Agents; Antimalarials; Artemisinins; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Young Adult | 2018 |
Choreoathetosis - an unusual adverse effect of dihydroartemisinin-piperaquine: a case report.
Topics: Adult; Antimalarials; Artemisinins; Athetosis; Black People; Chorea; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Quinolines; Treatment Outcome | 2017 |
Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Carrier State; Child; Child, Preschool; Disease Reservoirs; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pharmacy and Therapeutics Committee; Pilot Projects; Plasmodium falciparum; Primaquine; Quinolines; Risk Factors; Young Adult | 2018 |
Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2017 |
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Topics: Adolescent; Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Quinolines; Treatment Failure | 2018 |
Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.
Topics: Amodiaquine; Antimalarials; Area Under Curve; Artemisinins; Biotransformation; Drug Administration Schedule; Drug Combinations; Half-Life; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Tablets; Young Adult | 2018 |
Plasmodium falciparum Plasmepsin 2 Duplications, West Africa.
Topics: Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mali; Pilot Projects; Plasmodium falciparum; Quinolines | 2018 |
Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Comoros; DNA, Protozoan; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Primaquine; Quinolines; Treatment Outcome; Young Adult | 2018 |
Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome | 2018 |
Dihydroartemisinin-piperaquine treatment failure in uncomplicated Plasmodium falciparum malaria case imported from Ethiopia.
Topics: Adult; Artemisinins; Communicable Diseases, Imported; Drug Combinations; Ethiopia; Female; Humans; Italy; Malaria, Falciparum; Quinolines; Treatment Failure | 2018 |
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.
Topics: Animals; Antimalarials; Cambodia; Cell Shape; Chloroquine; Drug Resistance; Gene Dosage; Gene Editing; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Parasites; Plasmodium falciparum; Protozoan Proteins; Quinolines; Verapamil | 2018 |
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Theoretical; Plasmodium falciparum; Quinolines | 2018 |
Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa.
Topics: Africa; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Cambodia; DNA Copy Number Variations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2018 |
Topics: Antimalarials; Artemisinins; Artesunate; Computer Simulation; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure | 2018 |
Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Healthy Volunteers; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mass Drug Administration; Middle Aged; Papua New Guinea; Patient Safety; Prospective Studies; Quinolines | 2018 |
Cryptic severe
Topics: Administration, Intravenous; Administration, Oral; Antimalarials; Artemisinins; Artesunate; Humans; Italy; Malaria, Falciparum; Male; Middle Aged; Morocco; Plasmodium falciparum; Quinolines; Transients and Migrants; Treatment Outcome | 2018 |
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Prospective Studies; Quinolines; Tanzania | 2018 |
Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
Topics: Africa; Antimalarials; Artemisinins; Doxycycline; Drug Combinations; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyrimethamine; Quinolines; Sulfadoxine | 2018 |
Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Aspartic Acid Endopeptidases; Child; Chloroquine; Drug Resistance; Folic Acid Antagonists; Humans; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines; Uganda | 2019 |
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Microbial Sensitivity Tests; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Quinolines; Real-Time Polymerase Chain Reaction; Vietnam; Young Adult | 2019 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
Baseline
Topics: Animals; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; DNA Copy Number Variations; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Quinolines; Senegal; Treatment Failure | 2019 |
Case Report: Hyperreactive Malarial Splenomegaly Syndrome Diagnosed with Loop-Mediated Isothermal Amplification and Treated with Artemisinin-Based Combination Therapy.
Topics: Adolescent; Antibodies, Protozoan; Antimalarials; Artemisinins; Belgium; Chronic Disease; Drug Therapy, Combination; Guinea; Humans; Malaria, Falciparum; Male; Nucleic Acid Amplification Techniques; Plasmodium falciparum; Quinolines; Splenomegaly; Temperature | 2019 |
High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Tanzania | 2019 |
Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients.
Topics: Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Electrocardiography; Female; Humans; Long QT Syndrome; Malaria, Falciparum; Male; Middle Aged; Quinolines; Retrospective Studies | 2019 |
Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention.
Topics: Adult; Age Factors; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers
Topics: Algorithms; Antigens, Protozoan; Antimalarials; Artemisinins; Biomarkers; Clinical Trials as Topic; Gene Expression; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Merozoite Surface Protein 1; Models, Statistical; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Quinolines; Time Factors; Treatment Outcome | 2019 |
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study.
Topics: Alleles; Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance, Multiple; Drug Therapy, Combination; Genome-Wide Association Study; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Phylogeny; Phylogeography; Plasmodium falciparum; Protozoan Proteins; Quinolines; Whole Genome Sequencing | 2019 |
Potential of artemisinin-based combination therapies to block malaria transmission.
Topics: Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Quinolines | 2013 |
Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines; Niger; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2013 |
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
Topics: Antimalarials; Artemisinins; Benzothiazoles; Biomarkers; Cambodia; Diamines; DNA Copy Number Variations; Drug Combinations; Drug Resistance, Multiple; Epidemiological Monitoring; Gene Expression; Humans; Malaria, Falciparum; Microscopy, Fluorescence; Multidrug Resistance-Associated Proteins; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2013 |
[Treatment of severe and uncomplicated falciparum malaria in children in France].
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Ethanolamines; Fluorenes; France; Humans; Malaria, Falciparum; Proguanil; Quinolines | 2013 |
Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
Topics: Acute Disease; Antimalarials; Artemisinins; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines | 2014 |
Competition between Plasmodium falciparum strains in clinical infections during in vitro culture adaptation.
Topics: Alleles; Antigens, Protozoan; Antimalarials; Artemisinins; DNA, Protozoan; Drug Resistance; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Quinolines; Tetrahydrofolate Dehydrogenase | 2014 |
Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.
Topics: Amino Acid Sequence; Antimalarials; Artemisinins; Biological Transport; Chloroquine; Chromosomes; Drug Resistance, Multiple; Erythrocytes; Humans; INDEL Mutation; Malaria, Falciparum; Mefloquine; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinolines; Thailand | 2014 |
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
Topics: Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines; Treatment Failure | 2015 |
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Antimanic Agents; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Genetic Variation; Humans; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2015 |
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.
Topics: Africa; Antimalarials; Artemisinins; Cost-Benefit Analysis; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Models, Theoretical; Quinolines; Seasons | 2014 |
In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; China; Drug Resistance; Female; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Middle Aged; Myanmar; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Young Adult | 2015 |
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.
Topics: Africa; Antimalarials; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Quinolines | 2015 |
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Cohort Studies; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinolines; Randomized Controlled Trials as Topic; Treatment Failure; Young Adult | 2015 |
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Models, Biological; Post-Exposure Prophylaxis; Prevalence; Primaquine; Quinolines; Young Adult; Zambia | 2015 |
Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Biological Availability; Dietary Fats; Drug Combinations; Female; Follow-Up Studies; Food-Drug Interactions; Humans; Infant, Newborn; Malaria, Falciparum; Models, Statistical; Papua New Guinea; Pregnancy; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2015 |
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Chloroquine; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Young Adult | 2015 |
Measuring windows of selection for anti-malarial drug treatments.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Models, Biological; Plasmodium falciparum; Quinolines | 2015 |
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Resistance; Humans; Immunity, Innate; Malaria, Falciparum; Mefloquine; Models, Statistical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in Africa.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Markov Chains; Models, Biological; Models, Economic; Plasmodium falciparum; Quinolines; Recurrence | 2015 |
High Antimalarial Efficacy of Dihydroartemisinin-Piperaquine on the China-Myanmar Border: The Calm Before the Storm.
Topics: Antimalarials; Artemisinins; China; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Myanmar; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene.
Topics: Artemisinins; China; Drug Resistance, Multiple; Genotype; Malaria, Falciparum; Mutation; Myanmar; Plasmodium falciparum; Quinolines | 2015 |
Optimum population-level use of artemisinin combination therapies: a modelling study.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Administration Schedule; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure | 2015 |
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Cambodia; Female; Humans; Malaria, Falciparum; Male; Parasites; Plasmodium falciparum; Prospective Studies; Quinolines; Retrospective Studies; Survival Rate; Treatment Failure; Treatment Outcome; Young Adult | 2015 |
Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.
Topics: Antimalarials; Artemisinins; Atovaquone; Base Sequence; Cambodia; DNA, Protozoan; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Quinolines; Sequence Analysis, DNA; Thailand | 2015 |
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Cohort Studies; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prospective Studies; Quinolines; Young Adult | 2016 |
Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Azithromycin; Biological Availability; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mass Spectrometry; Models, Biological; Papua New Guinea; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Young Adult | 2016 |
Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; India; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinolines | 2016 |
Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Myanmar; Parasitemia; Prospective Studies; Protozoan Proteins; Quinolines; Young Adult | 2016 |
[Multiple and successive treatment failures in a patient infected by Plasmodium falciparum in Cambodia and treated by dihydroartemisinin-piperaquine].
Topics: Antimalarials; Artemisinins; Cambodia; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinolines; Recurrence; Treatment Failure | 2016 |
[Malaria in the Comoros Archipelago in 2015: status after 15 years of fight].
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Comoros; Female; Humans; Incidence; Infant; Infection Control; Lactones; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Quinolines; Surveys and Questionnaires; Young Adult | 2016 |
Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.
Topics: Antimalarials; Chemoprevention; Computer Simulation; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Models, Theoretical; Quinolines | 2016 |
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria, Falciparum; Male; Prospective Studies; Quinolines | 2016 |
Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Asymptomatic Diseases; Cambodia; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Quinolines; Real-Time Polymerase Chain Reaction; Treatment Outcome; Young Adult | 2016 |
Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient.
Topics: Adult; Antimalarials; Artemisinins; Djibouti; Drug Therapy, Combination; France; Humans; Malaria, Falciparum; Male; Military Personnel; Overweight; Quinolines; Treatment Failure | 2016 |
Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia.
Topics: Adult; Antimalarials; Artemisinins; Ethiopia; France; Humans; Malaria, Falciparum; Military Personnel; Overweight; Quinolines; Treatment Failure | 2016 |
New genetic marker for piperaquine resistance in Plasmodium falciparum.
Topics: Antimalarials; Drug Resistance; Genetic Markers; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2017 |
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.
Topics: Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Biomarkers; Cambodia; DNA Copy Number Variations; Drug Resistance, Multiple; Genetic Association Studies; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Treatment Failure | 2017 |
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Cost of Illness; Cross-Sectional Studies; Family Characteristics; Female; Guideline Adherence; Health Expenditures; Humans; Indonesia; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Patient Acceptance of Health Care; Quinolines; Random Allocation; Young Adult | 2016 |
Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination?
Topics: Antimalarials; Artemisinins; Malaria, Falciparum; Quinolines | 2017 |
Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cameroon; Child; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymorphism, Genetic; Prospective Studies; Protozoan Proteins; Quinolines; Treatment Outcome; Volunteers; Young Adult | 2016 |
How to tackle antimalarial resistance?
Topics: Antimalarials; Artemisinins; Clinical Studies as Topic; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Quinolines | 2017 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Resistance; Endemic Diseases; Female; Humans; Incidence; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines; Time Factors; Treatment Failure; Vietnam; Young Adult | 2017 |
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.
Topics: Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Recurrence; Treatment Failure | 2017 |
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.
Topics: Antimalarials; Artemisinins; Cambodia; Drug Resistance; Genotype; Humans; Laos; Malaria, Falciparum; Microsatellite Repeats; Molecular Epidemiology; Mutation; Plasmodium falciparum; Quinolines; Thailand | 2017 |
Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa.
Topics: Adult; Africa; Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance; Drug Therapy, Combination; Equatorial Guinea; Humans; Malaria, Falciparum; Male; Mutation; Papua New Guinea; Parasitemia; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinolines | 2017 |
Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.
Topics: Antimalarials; Artemisinins; Chemoprevention; Computer Simulation; Drug Administration Schedule; Drug Therapy, Combination; Humans; Malaria, Falciparum; Quinolines; Treatment Outcome | 2017 |
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic | 2009 |
Artemisinin combination therapy for malaria: beyond good efficacy.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Quinolines; Treatment Outcome | 2009 |
Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Cambodia; Child; Drug Administration Schedule; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Pilot Projects; Plasmodium falciparum; Population Surveillance; Primaquine; Quinolines; Treatment Outcome | 2010 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Blood Chemical Analysis; Capillaries; Child; Child, Preschool; Drug Combinations; Female; Fingers; Humans; Malaria, Falciparum; Male; Middle Aged; Phlebotomy; Plasma; Quinolines; Randomized Controlled Trials as Topic | 2010 |
Severe congenital malaria acquired in utero.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Quinolines | 2010 |
Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure.
Topics: Adolescent; Adult; Antimalarials; Cambodia; Child; Child, Preschool; Chloroquine; Chromatography, Liquid; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinine; Quinolines; Selection, Genetic; Serum; Tandem Mass Spectrometry; Young Adult | 2010 |
Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites.
Topics: Antimalarials; Artemisinins; DNA Copy Number Variations; Drug Resistance; Drug Therapy, Combination; Genome, Protozoan; Malaria, Falciparum; Phenotype; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Quinolines | 2011 |
Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission.
Topics: Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Indonesia; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Malaria, Vivax; Population Surveillance; Pregnancy; Prospective Studies; Quinolines; Risk Factors | 2011 |
Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs.
Topics: Antimalarials; Artemisinins; Artesunate; Cells, Cultured; Erythrocytes; Host-Parasite Interactions; Malaria, Falciparum; Microscopy, Electron, Transmission; Plasmodium falciparum; Quinine; Quinolines; Ribosomes; Trophozoites | 2011 |
Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Drug Administration Schedule; Drug Therapy, Combination; Female; Half-Life; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Thailand; Young Adult | 2011 |
Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred C57BL; Microscopy; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Quinolines; Secondary Prevention; Survival Rate | 2012 |
Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Area Under Curve; Chromatography, Liquid; Female; Humans; Malaria, Falciparum; Mass Spectrometry; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Sudan; Treatment Outcome | 2012 |
[In vitro sensitivity of Plasmodium falciparum isolates from China-Myanmar border region to chloroquine, piperaquine and pyronaridine].
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; China; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Myanmar; Naphthyridines; Plasmodium falciparum; Quinolines; Young Adult | 2012 |
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Discovery; Ethanolamines; Fluorenes; Host-Pathogen Interactions; Humans; Malaria, Falciparum; Mefloquine; Models, Statistical; Plasmodium falciparum; Quinolines | 2012 |
A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Biological Availability; Drug Combinations; Female; Humans; Malaria, Falciparum; Metabolic Clearance Rate; Models, Biological; Nonlinear Dynamics; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Sudan; Young Adult | 2012 |
Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines; Treatment Outcome; Young Adult | 2013 |
Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection.
Topics: Antimalarials; Half-Life; Humans; Malaria, Falciparum; Quinolines; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2003 |
[Factors affecting the in vitro microtest for drug sensitivity of Plasmodium falciparum].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Blood; Chloroquine; Humans; Malaria, Falciparum; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2003 |
Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.
Topics: Adult; Antimalarials; Child; Dose-Response Relationship, Drug; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Quinolines; Tablets | 2004 |
Once-daily combination therapy for uncomplicated malaria: is this the way forward?
Topics: Animals; Antimalarials; Artemisinins; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2005 |
Artemisinin combination therapies.
Topics: Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child, Preschool; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Quinolines; Sesquiterpenes | 2006 |
Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Fever; Gestational Age; Gravidity; Humans; Malaria, Falciparum; Parity; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Infectious; Quinolines; Retrospective Studies; Thailand | 2008 |
Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
Topics: Adult; Animals; Antimalarials; Artemisinins; Cross-Sectional Studies; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Surveys and Questionnaires | 2008 |
[In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and artesunate in Yuxi prefecture of Yunnan province].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; In Vitro Techniques; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Plasmodium falciparum; Quinolines; Sesquiterpenes | 1998 |